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ABSTRACT 
Diabetes is one of the leading causes of death and disability in the world. Even 
though insulin was discovered in 1920, an intense research on diabetes has been 
conducted during the last five decades and this is because of the market size. The 
huge demand is creating the need for the development of new approaches. This 
project involved the research aimed at better understanding and improvements in 
performance of glucose biosensors.  
 
In general, high surface area electrodes are desired as the high surface area 
provides more active sites for electrochemical reactions, and hence higher kinetic 
rate capability. Therefore, the determination of the active electrochemical surface 
area of the electrode is very important. A study has been conducted to determine the 
real electrochemical surface area of the Pelikan screen printed electrodes (SPEs) 
and a method has been optimised and established by Pelikan for the evaluation of 
their SPEs. Another very important issue that most of the current blood glucose 
monitoring tests are facing is the haematocrit effect, since the haematocrit 
differences observed in the blood samples can significantly affect glucose 
measurements. Therefore a study has been conducted in order to observe the 
absorption of the blood samples into the working electrode paste according to the 
haematocrit level. 
The second part of the study included the characterisation of the novel conjugated 
polymer made of N-(N, N’-diethyldicarbamoyl ethyl amido ethyl) aniline (NDDEAEA), 
the optimization of the conditions for the electrochemical polymerization, their 
application in grafting and finally the development of NDDEAEA -based glucose 
biosensor. The new conducting polymer, acted as a matrix for the biosensor 
 II 
 
fabrication in this study, possesses macroiniferter properties and is capable of 
initiation free radical-initiated addition polymerisation after formation of the 
polyaniline (PANI) material while preserving or even enhancing some of the PANI’s 
electrochemical properties. This material can potentially be used in the construction 
of novel Pelikan electrodes with enhanced integration functionalities, e.g. grafting 
non-adhesive polymer coatings to assure that the poor performance in sensors as a 
result of impact of blood components can be mitigated. 
The final study included the development and optimisation of the reaction conditions 
for grafting a hyperbranched polymer onto the surface of the multi-walled carbon 
nanotubes (MWCNT), using the A3 and B2 approach (described below). The aim of 
this work was achieving further increase in the sensitivity of Pelikan sensors. 
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RATIONALE FOR RESEARCH 
 
Diabetes is one of the leading causes of death and disability in the world. 171 million 
people in the world are suffering from this disease and several studies have 
demonstrated the likely increase of this figure to 366 million by 2030. The quick 
diagnosis and early prevention are critical for the control of the disease. Forty years 
have passed since Clark and Lyons proposed the concept of glucose enzyme 
electrodes. Since then, excellent economic prospects and fascinating potential for 
basic research have led to many sensor designs and detection principles for the 
biosensing of glucose. 
 
Because of this intense competition, the companies have resorted to a strategy 
where the existing technology is rapidly evolved and “re-packaged” to meet 
commercial objectives, such as small size and fast response and consequently the 
technology has moved far away from the theoretical understanding of the 
functionality of these devices, generating a serious gap in the knowledge required for 
further optimisation. 
 
As this field enters the fifth decade of intense research, the market size and the huge 
demand are creating the need for the development of new approaches. This project 
was aimed at better understanding and improvements in performance of glucose 
biosensors, in particular these produced by Pelikan – sponsor of this work. 
 
The first part of the study includes the study of different aspects of the Pelikan 
screen printed electrodes. More precisely the determination of their real surface area 
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and an investigation of the impact of major haematocrit effect on sensor response 
which most of the present commercial electrochemical glucose biosensors seem to 
present was carried out.  
 
The second part of the study includes the characterisation of the NDDEAEA, the 
optimization of the conditions for the electrochemical polymerization, their application 
in grafting and finally the development of a glucose biosensor. The new conducting 
polymer N-(N, N’-diethyldicarbamoyl ethyl amido ethyl) aniline (NDDEAEA), which 
was characterized and acted as a matrix for the biosensor fabrication in this study, 
can act as a macroiniferter and is capable of electrochemical polymerisation to form 
PANI-based materials in various formats capable of utilization in other reactions, 
such as participation in free radical-initiated addition polymerisation after formation of 
the PANI material while preserving or even enhancing some of the PANI’s 
properties. 
 
The final study includes the development and optimisation of the reaction conditions 
to grafting a hyperbranched polymer onto the surface of the multi-walled carbon 
nanotubes (MWCNT), using the A3 + B2 approach. 
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1.1 BRIEF BACKGROUND 
 
Diabetes is a metabolic disorder which occurs either because of a lack of insulin or 
because of the presence of factors that opposes the action of insulin. Diabetes is a 
chronic condition that without treatment can have very serious consequences. The 
health implications of diabetes are astounding, since this disease is associated with 
morbidity and mortality. Over time, diabetes can lead to blindness, kidney failure, 
and nerve damage. Diabetes is also an important factor in accelerating the 
hardening and narrowing of the arteries (atherosclerosis), leading to strokes, 
coronary heart disease, and other blood vessel diseases. (1) , (2) The care and 
management of diabetes involve heavy costs. It has been characterised as one of 
the largest therapeutic segments of global pharmaceutical sales. In 2005 the 
generated sales were over $15 billion and in 2009 it was valued at $25 billion. It 
should be noted that people with diabetes incur two to five times higher medical 
costs than people without diabetes. These medical costs include medical visits, 
admission to a hospital and the purchase of supplies and medications. 
 
There is currently no actual cure for diabetes and the control of elevated blood 
glucose levels, without causing abnormally low levels, is the major goal in treating 
diabetes. This is now easily achieved with a blood glucose meter (glucose 
biosensor) and the invention of this technology was one of the most important steps 
in managing diabetes, since it also reduces the risk of long-term complications. In 
comparison with conventional methods of glucose testing, glucose biosensors 
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provide a rapid and easy method of testing blood glucose levels. This is one of the 
major reasons that the glucose biosensors occupy 85% of the current world market 
for biosensors and worth approximatelly $6.9 billion. (3) , (4) This figure will reach 
$11.5 billion by 2012 according to the Global Industry Analysts. (5) Currently, there 
are more than 56 commercialised devices for detecting blood glucose levels, 
manufactured by 18 different companies but four multinational companies dominate 
the biosensor industry: Roche Diagnostics, LifeScan, Abbott and Bayer.  
 
Nowadays the glucose biosensors are more accurate and easy to use. Netherless 
are still less precise and accurate than the methods used in the laboratories. 
Therefore further improvements should be achieved. 
 
1.2 DIABETES MELLITUS 
 
Diabetes Mellitus (Diabetes) (2) is characterised by the presence of excess of 
glucose in the blood and tissues of the body. It is a metabolic disorder in which the 
pancreas underproduces or does not produce insulin. Insulin is a hormone produced 
by the pancreas that is required by cells of the body in order to use glucose, the 
major source of energy for the human body. There are three main types of diabetes: 
Type I diabetes, Type II diabetes and Gestational Diabetes. (6) 
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1.2.1 Type I diabetes  
Type I diabetes was previously known as insulin-dependant diabetes and affects 
approximately 10% of all people with diabetes. It is rare in the first nine months of life 
and has peak incidences at twelve and between twenty to thirty five years old. (7) It 
is due to the destruction of beta-cells in the pancreatic islets of Langerhans with 
resulting loss of insulin production and finally in hyperglycaemia. The process of 
islets destruction probably begins very early in life and is known to start several 
years before the clinical onset of diabetes. Clinically a person with this disorder 
presents a number of symptoms, including: polydipsia (increased thirst), which is an 
attempt to compensate for fluid loss; polyuria (frequent passage of urine), which is 
due to the presence of excess glucose in the urine; muscle cramps, which are due to 
electrolyte disturbances because of the fluid loss; weight loss due to the lack of 
insulin and consequently to the break-down of proteins and fat despite increased 
appetite, blurred vision due to the excess accumulation of glucose in the eye lenses, 
nausea, vomiting and abdominal pain. (8)  
 
1.2.2 Type II diabetes 
Type II diabetes previously known as non-insulin dependent diabetes, affects 
approximately 90% of all people with diabetes and is usually found in middle aged or 
older patients. Type II diabetes is due to a combination of disorders with differing 
progression and outlook. This combination of disorders include resistance to the 
action of insulin in peripherical tissues such as muscle and fat cells, the failure of the 
insulin secreting cells of the pancreas to produce sufficient insulin and the failure of 
insulin to inhibit the production of glucose in the liver.  Symptoms of people with type 
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II diabetes include: polydipsia, polyuria, increased appetite, fatigue, erectile 
dysfunction and frequent or slow-healing infections. (5) 
 
1.2.3 Gestational Diabetes 
Gestational diabetes occurs during pregnancy. The placenta, during pregnancy 
transfers nutrients to the fetus and also produces a number of hormones (e.g.cortisol 
and progesterone) that interfere with the body's usual response to insulin (insulin 
resistance). When pregnant women present high blood glucose levels because their 
pancreas cannot produce extra quantities of insulin in order to compensate for 
insulin resistance, then these women are consider to have gestational diabetes. 
Gestational diabetes affects two to four percent of pregnancies, depending on the 
population studied. (9) Gestational diabetes can be characterised as a treatable 
condition, since women can effectively decrease several risks attributed to the 
specific disease by controlling their blood glucose levels. 
 
1.3 INCIDENCE - A MAJOR WORLD PROBLEM 
Diabetes is a major world health problem. In 2000, it was estimated by the world 
health organisation, that the number of diabetics worldwide was 171 million and 
approximately 4 million deaths each year were caused by diabetes (9% of deaths 
worldwide). Several studies on the prevalence of diabetes have shown that the 
above figure of 171 million is projected to rise to 366 million by 2030. (10) These 
studies usually include data on diabetes prevalence according to age, sex and 
region. The prevalence of diabetes among people aged 20-79 years will be 6.4% 
affecting 285 million adults in 2010 and by 2030 this figure will increase to 7.7%, 
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affecting 439 million people. (11) The prevalence of diabetes is higher in men than 
women despite the fact that at the moment there is, worldwide, a significantly higher 
amount of women suffering from diabetes. (12) The same study also demonstrated 
that the most important demographic change to diabetes prevalence worldwide 
appears to be the increase in the proportion of people below the age of sixty-five 
years. 
Diabetes was once considered to be a disease afflicting wealthy countries. (13) 
Nowadays, it is affecting low income and developing countries. In the future the 
largest proportional and absolute increase will occur in developing countries, where 
the prevalence will rise from 4.2% to 5.6%. (14) A recent study showed that 
between 2010 and 2030 there will be a 69% increase of diabetics in the developing 
countries and 20% increase of diabetics in developed countries. (11) 
 
Regionally by 2025, the adult diabetic population is expected to double in India to 
about 73 million and in China to 46 million. It is worthy to mention that the 36% of 
the anticipated absolute global increase of diabetics will occur in India and China 
alone. (11) At the same time, diabetes prevalence is expected to increase to 2.8% 
of the adult population in Africa and 7.2% in South and Central America. The 
European Region, with 48 million, and Western Pacific Region, with 43 million, 
currently have the highest number of people with diabetes. However the 
prevalence rate of the Western Pacific Region at 3.1% is significantly lower than 
7.9% in the North American Region and 7.8% in the European Region (Fig.1). (15), 
(16) 
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Figure 1: Estimated prevalence of diabetes in selected countries by 2025 (14) 
 
It is worthy of note that by 2010, cases of type 2 diabetes are projected to rise 111%, 
from 62 million to 132 million, and in mainland China alone, the increase over the 
next 10 years is predicted to be 35-36 million. In general, worlwide, type 2 diabetes 
clearly predominates, but several reports clarify that the 4.3 million cases of type I 
diabetes are expected to increase to 5.3 million cases by 2010. (15)  
 
1.4 TREATMENTS 
 
Diabetes is a chronic condition that without treatment can have very serious 
consequences. The overall health implications of diabetes are astounding. The 
disease is associated with morbidity and mortality and studies have shown that 
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persons diagnosed with diabetes before the age of forty tend to present a life 
decrease, which for men amounts to 12 years and for women to 19 years. 
 
The complications of diabetes could be mitigated by controlling the blood glucose 
levels.  In general the type I diabetes can be treated with insulin, exercise and diet, 
while type II diabetes is initially treated with weight reduction, diet and exercise. 
However when all the above fail to control the high glucose levels, oral medications 
(e.g. metformin, sulphonyl ureas, thialzoldinediones, etc.) or even insulin are used. 
(17) 
 
It is worthy to note that it is necessary not only to treat the diabetes but to monitor 
the effects of treatment on blood glucose levels to avoid overtreatment or 
undertreatment of the diabetes. (18)  
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1.5 HOME URINE/BLOOD GLUCOSEMONITORING 
 
Urine and blood glucose self monitoring are the two primary methods used by the 
person with diabetes to monitor their diabetes control. 
 
1.5.1 Urine glucose monitoring 
Urine glucose monitoring (19), (20) is a viable, cost-effective way of monitoring 
diabetes control, but has a number of limitations and is not a substitute for blood 
glucose monitoring. There are two types of urine glucose tests, which are based on a 
chemical reaction. By placing a specific strip or tablet in a urine specimen a chemical 
reaction occurs resulting to a colour change according to the glucose level presented 
in the sample. The specific colour is then matched against to a colour chart provided 
by the manufacturer and the result is obtained. In more details the first type, the 
copper reduction test, uses cupric sulfate. In the presence of glucose, cupric sulfate, 
which is blue, changes to cuprous oxide, which is green to orange. The second type 
of urine glucose test, called the glucose oxidase test, uses the chemical toluidine 
and the enzyme glucose oxidase. Glucose oxidase converts the glucose in urine to 
gluconic acid and hydrogen peroxide. The interaction of the hydrogen peroxide with 
the toluidine causes a change in colour. The main limitations of this kind of test is 
firstly the fact that the cupric sulfate and the glucose oxidase can react with 
substances other than glucose in the urine and lead to false positive results, like 
aspirin, penicillin, vitamin C, and cephalosporin-type antibiotics and secondly it 
cannot distinguish between low and normal blood glucose levels, or high and very 
high blood glucose levels. However, urine glucose monitoring is particularly helpful in 
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persons at low risk of hypoglycaemia and whose blood glucose levels are not too 
high and generally stable. (21)  
 
1.5.2 Blood glucose monitoring 
Blood glucose monitornig (22), (23) can be achieved in several ways. The pricking of 
the finger with a small lancet in order to produce a droplet of blood, which is placed 
onto the strip and into a meter that displays the blood glucose level, is the most 
popular way of testing. In the commerce can be found several meters, presenting 
various features, sizes and costs, as well as alternative testing sites such as the 
upper arm, forearm, base of the thumb and thigh. It is worthy to mention though that 
testing at alternative sites, may give slightly different results than these obtained by 
the conventional fingertip pricking. (24)  
 
1.6 GLUCOSE METERS 
 
Before focusing on the glucose biosensors it is importamt to have a quick look in the 
past, in order to get a broader understanding of their importance. 
 
1.6.1 Colorimetric Strips 
Dextrostix was a paper strip developed and introduced to the market in 1965 by 
Ames, a division of Miles laboratories. By adding one drop of blood on the strip, a 
blue colour was being developed which was interpreted by comparing it to a colour 
chart, which was indicating an approximation of the blood glucose level. 
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People who were following this procedure on a regular basis frequently got to read 
Dextrostix strips very well. But for most people because of the limited usage, the 
interpretation wasn’t always successful. (25), (26), (27), (28). 
 
1.6.2 Ames Reflectance Meter 
The solution came with the development of the Ames Reflectance Meter in 1971 by 
Anton H. Clemens. The device was able to read and interpret the Dextrostix strips. In 
more details the Ames Reflectance Meter was a light meter that read reflected light. 
This reflected light was sent to a photoelectric cell and a read out was given. 
Although the instrument was more able to read the minor changes in the reflection of 
the darkness and lightness of the shade of blue, adding a certain degree of 
interpretation accuracy, was very expensive, heavy, requiring also connection to an 
electrical outlet for power and most important a prescription. It is worthy to note 
though that this instrument was the pioneer which eventually led to a variety of other 
products. (29)  
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1.7 GLUCOSE BIOSENSORS 
 
1.7.1 Clark Oxygen Electrode  
Prof. Lelend Clark Jnr was immortalised by his invention of the Clark Oxygen 
Electrode in 1956.(Fig.2)  
 
 
Figure 2:Clark Oxygen Electrode (30) 
 
A few years later in 1962 at a New York Academy of Sciences symposium Clark 
described how "to make electrochemical sensors more intelligent, "by adding" 
enzyme transducers as membrane enclosed sandwiches". By performing an 
experiment, he managed to entrap glucose oxidase at a Clark oxygen electrode by 
using a dialysis membrane and demonstrated that the decreased measured oxygen 
was proportional to the glucose concentration. The sensor invented by Clark 
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comprised the basis of numerous variations on the basic design and many other 
oxidase enzymes were immobilised by various workers in subsequent publications. 
(30) 
 
In nature, glucose oxidase as well as other oxidase enzymes act by oxidising their 
substrates, accepting electrons in the process and thereby changing to an 
inactivated reduced state. The purified enzymes are normally returned to their active 
oxidised state by transferring these electrons to molecular oxygen, resulting in the 
production of hydrogen peroxide. (Fig.3) 
 
 
Figure 3:First generation glucose biosensor schematic (4) 
 
It is worthy to note at this point that the glucose concentration can be also measured 
amperometrically at a potential of +0.7V versus a silver-silver chloride electrode 
when a platinum working electrode is used, normally under strongly alkaline 
conditions.  
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1.7.2 Yellow Springs Instrument 
In 1975 the construction of biosensors based on the Clark’s approach became a 
commercial reality with the successful relaunch of the Yellow Springs Instrument. (3) 
The amperometric detection of hydrogen peroxide consisted the fundamental basis 
of these instruments.  
While they remained in the market eversince and they are met in hospitals and 
laboratories in all over the world, over the years the biosensor constuction hasn’t 
changed significantly. The basic format is based on the immobilisation of glucose 
oxidase between two membrane layers. The outer polycarbonate membrane retains 
the enzyme, allowing glucose to pass, but prevents many larger molecules from 
entering, reducing the interference. The glucose enters the enzyme layer, where it is 
oxidised, and hydrogen peroxide is produced. This passes through the cellulose 
acetate membrane to a platinum electrode where it is measured amperometrically. 
The second membrane acts as a further size exclusion barrier preventing many 
other potentially interfering (electroactive) compounds from reaching the electrode 
surface. What has been concluded by the construction of these devices is that they 
are robust but not straightforward to miniaturise, expensive and finally the high 
detection voltage required makes the system prone to interference in the absence of 
the membrane structures utilised. (31) 
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1.7.3 Mediated Biosensors 
The problems related to the sensitivity of O2 concentration and the interference 
signals produced by ascorbate, urate and paracetamol were overcomed with the use 
of some compounds known in our days as mediators. (32)  
Around 1980 a group of scientists based at Cranfield and Oxford Universities, 
working on fuel cells realised that the electron transfer compounds used for their 
projects could have a promising use in the biosensor application. (33), (34)  
The mediators can shuttle electrons between the redox center of the enzyme and the 
electrode. The most important examples of these mediators, are mediators based on 
the ferrocene and its derivatives, since they have a wide range of redox potentials. 
One of the most important breakthroughs was the incorporation of the mediators in 
the glucose biosensors, since they superceded the reflectance devices for home 
blood glucose testing. 
It has to be noted though that one of the major drawback of the mediators is the fact 
that they are relatively soluble, resulting in short operational lifetimes and 
irreproducible results. In the case of the blood glucose sensing though this is 
acceptable since for the one shot use they have been proved robust and accurate. 
(35) 
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1.7.4 General principles 
But what exactly is the biosensor and which are the key components for its 
functionality? “A biosensor is an analytical tool or system consisting of an 
immobilised biological material which converts information about the properties of 
the analyte into a quantifiable signal via a suitable transducer.” (36) In principle many 
transducers can be used in a biosensor for the measurement of glucose but, 
electrochemical methods have dominated the market, mainly because of the 
sensitivity, reproducibility, the inexpensive manufacture that they can offer and the 
easy maintance. (5) The most often electrochemical method employed is the 
amperometry, which relies on the application of a potential between two electrodes 
and the measurement of the resultant current flow. This is easily achieved in a three 
electrode cell, composed by a reference electrode, typically a Ag/AgCl electrode, a 
working electrode, which is usually made of a noble metal or carbon and a counter or 
auxillary electrode.  
 
1.7.4a Enzyme 
Another key component in the manufacture of a glucose biosensor is the enzyme. 
The most commonly used enzymes in the design of glucose biosensors contain 
redox groups that change redox state during the biochemical reaction. (37) Enzymes 
of this type are glucose oxidase and glucose dehydrogenase, which have a wide 
application in the commercial devices. The enzymes are proteins, consisted of one 
or more polypeptide chains with high molecular weights. The most significant 
property is the fact that they are highly specific in relation to the substrate molecules. 
The chemical bonding, the physical adsorption and the entrapment in a polymeric 
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matrix are the three main immobilisation methods used for the attachment of the 
enzyme to the transducer. 
 
1.7.4b Mediators 
As has been mentioned earlier, the performance of the glucose biosensors is highly 
linked with the mediators employed. (38) Some of the most significant examples of 
mediatord found in the commercial blood glucose sensors are the ferrocene and its 
derivatives, ferricyanide, osmium and TMPD. (Table 1) 
 
Table 1: Examples of mediators 
Device Name Mediator 
Precision Ferrocene 
Elite Ferricyanide 
Sure Step Ferricyanide 
AccuCheck Ferricyanide 
FreeStyle Osmium 
Pelikan Sun TMPD 
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1.7.4c Polymers 
Blood is a physiological material containing solutes and various species that might 
be electrochemically active and interfere with the glucose measurements. These 
substances are being binded to the electrode surface, causing the fouling or the loss 
of the sensor response. These problems could be solved by the application of a 
permselective coating to the sensor. These permselective coatings are known as 
polymers. Polymers are also used in order to entrap a mediator or a biological 
material close to the surface of an electrode. (39)  
 
There are many different types of polymers but several studies have demonstrated 
that the conducting polymers are suitable for the immobilisation of enzymes at 
electrode surfaces offering an additional advantage of electron transport between 
enzyme catalytic centre and electrode. (40), (41), (42) By applying the correct 
conditions, several monomers can be electrochemically polymerised on the 
electrode surface and form conductive films. The biological material (biomolecule) 
can be entrapped in the conducting film if it is present in the solution during the 
electrochemical polymerisation or alternatively it can be adsorbed or chemically 
grafted after the initial electropolymerisation of the conductive polymer. (43), (44), 
(41), (42)  
 
One of the most significant and widely used, conductive polymer is the polyaniline 
and its derivatives, because of the exceptional electrical, electrochemical and optical 
properties. (45) These are conjugated polymers which have the capability to conduct 
electrical charge and have been used both as an immobilisation media as well as a 
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physiological transducer, transforming the chemical signal into an electrical. (46) 
Their electrical conductivity is based on the electronic structure of their polymeric 
blackbone, which varies according to the applied potential and can be explained by 
the polaron formation. (47), (48) Upon oxidation, double bonds along the chain are 
broken leaving a radical and a positive charge unit (polaron) on the polymer chain. 
After further oxidation more polarons are formed along the chain and when the 
polaron concentration gets high enough the radical cations spread out through 
adjacent π structures across approximately eight bond lengths. The combination of 
two radicals, one from each polaron forms a new π bond. This results in the 
formation of a bipolaron which is more stable than two polarons than same distance 
apart. The bipolarons are free to move along the polymer chain and this action gives 
rise to electronic conductivity. It is also worthy to note that it is at this point in the 
oxidation process that the conductivity undergoes a marked increase.  (48) 
 
1.8 CURRENT COMMERCIAL HOME BLOOD GLUCOSE MONITORING 
 
Biosensors can be developed for many different applications. (49) They have been 
applied to a wide variety of analytical problems included in: medicine and healthcare, 
environmental protection and biotechnology. (50) The largest market opportunity is 
represented by the biomedical area and this is one of the major reasons that the 
biosensor research and development has been largely concentrated in the specific 
area. A single analyte dominates this market and this is glucose. Blood glucose 
sensors account for 85% of the current world market for biosensors and are the most 
widely studied and commercialised of all biosensors. (30) 
 
CHAPTER 1 – Introduction and Literature Review 
 
20 
 
Commercial blood glucose meters are produced by many companies worldwide. 
(Table 2) Although the biosensor industry is dominated by several multinational 
companies, the major players are Roche Diagnostics, LifeScan, Abbott and Bayer. 
(30)  
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Table 2: Market leading glucose biosensor companies in 2003 (30) 
 
Company Name Annual Sales (Millions) 
Roche Diagnostics $ 1494 
LifeScan $1288 
Abbott $977 
Bayer Diagnostics $460 
Becton Dickinson $23 
Hypoguard $19 
 
1.8.1 Roche Diagnostics 
Roche Diagnostics is one of the major healthcare companies, worldwide and now 
offers a range of biosensor products to researchers, physicians, patients, hospitals 
and laboratories. In May of 1997, Roche re-entered the biosensor market (after an 
early unsuccessful foray into the area in 1977) by purchasing all shares of the 
diagnostics and pharmaceuticals businesses of the Boehringer Mannheim Group, 
which had a successful biosensor programme. The purchase price was around 11 
billion US dollars. Roche Diagnostics reports that it now conducts research mainly 
into biosensors that permit near-painless, continuous measurement of blood glucose 
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level. It acquired from Boehringer Mannheim the very successful Accu-Chek family 
of products for blood-glucose monitoring. The blood glucose systems for patient self-
testing comprise blood glucose monitors (Table 3), test strips and lancing devices as 
well as diabetes data management for professional use. It is worthy to note that 
Roche has one of the few meters with an integrated lancing device. The Accu-Check 
Compact Plus has an integrated 17 test drum, which eliminates the need for strip 
handling. (30), (51)  However, the Compact still uses the last generation colorimetric 
strip technology while the Aviva, Active, Go and Advantage use the more modern 
electrochemical biosensor approach. 
 
Table 3: Blood glucose meters by Roche Diagnostics 
 
Device Sample 
Volume 
Time Specifications 
Accu-Chek Aviva 
System 
0.6 uL 5 sec 1. Review of past results right on 
the meter 
2. Audible test reminders 
Accu-Chek Active 
System 
1 uL 5 sec 1. Large memory capacity with 
averaging the results 
2. Underdosing detection 
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Accu-Chek Compact 
Plus System 
1.5 uL 5 sec 1. Integrated test strips 
2. Integrated Safety 
Accu-Chek Go 
System 
1.5 uL 5 sec 1. Acoustic test reminder 
2. Hypoglycemia threshold 
warning  
Accu-Chek Compact 
System 
1.5 uL 8 sec 1. Large memory capacity with 
averaging 
2. Maximum safety 
Accu-Chek 
Advantage / Accu-
Chek Sensor System 
4 uL 40 sec 1. Review of past results right on 
the meter 
2. Acoustic test reminder 
3. Visual hypoglycemia warning 
Accu-Chek Complete 
System 
4 uL 40 sec 1. Combines all information 
pertaining to blood sugar, insulin 
doses, carbohydrates, ketones, 
HbA1c, exercise, and event 
markers 
2. Large memory capacity with 
averaging 
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1.8.2 LifeScan 
LifeScan is part of the Johnson & Johnson family. The company became part of the 
biosensor market in 2001 by the acquisition of the diabetes care business of 
Inverness Medical. (30), (52) LifeScan presents an array of products for blood 
glucose testing on the market under the umbrella of One Touch products, like blood 
glucose meters (Table 4), test strips, lancets and lancing devices and diabetes 
management software. (53) The low volume, high performance devices are based 
on electrochemistry, while the Basic and SureStep still use colour reflectance 
technology. 
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Table 4:Blood glucose meters by LifeScan 
 
Device Sample 
Volume 
Time Specifications 
OneTouch Ultra 2 1 uL 5 sec 1. Multiple test sites 
OneTouch 
UltraSmart 
1 uL 5 sec 1. Multiple test sites 
2. Test results are entered 
automatically into 9 charts and 
graphs 
OneTouch 
UltraMini 
1 uL 5 sec 1. Small size 
OneTouch Ultra 1 uL 5 sec 1. Multiple test sites 
OneTouch Basic 10 uL 45 sec 1. Test memory with date and time 
OneTouch 
SureStep 
10uL 15 sec 1. Test memory with date and time 
2. Automatic 14-day, 30-day test 
averages 
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1.8.3 Abbott 
Abbott is a global, broad-based health care company supplying a range of products 
for the diagnosis and treatment of diseases. In 1996, it acquired MediSense for $867 
million, which was the first company to commercialise home blood glucose biosensor 
technology. Following the purchase of two further biosensor companies, Therasense 
for $1.2 billion and i-STAT for $392 million in early 2004, Abbott has cemented itself 
in the top three largest biosensor companies worldwide. (30), (54) The company 
offers a range instruments for blood glucose testing, including blood glucose meters 
(Table 5), strips and lancets. (55)  
 
Table 5:Blood glucose meters by Abbott 
 
Device Sample 
Volume 
Time Specifications 
FreeStyle Flash 0.3 uL 5 sec 1. Alternative site testing 
2. Presents 4 programmable 
alarms remind patients when 
to test 
FreeStyle Mini 0.3 uL 7 sec 1. Alternative site testing 
2. Presents 4 programmable 
alarms remind patients when 
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to test 
3. Large memory capacity 
4. Automatic 14-day test 
averages 
Precision Xtra 0.6 uL 5 sec 1. Auto Calibration 
2. Simple blood calibration 
Optium Xceed with 
Optium Xceed Plus test 
strips 
0.6 uL  5 sec 1. Large memory capacity  
2. Automatic 7-day, 14-day, 
30-day test averages 
3. Blood ketone testing 
4. Alternative site testing 
Optium Xceed w/o 
Optium Xceed Plus test 
strips 
1.5 uL  10 sec  1. Large memory capacity  
2. Automatic 7-day, 14-day, 
30-day test averages 
3. Blood ketone testing 
4. Alternative site testing 
MediSense Optium 25 uL 20 sec 1. Alternative site testing 
2. Blood ketone testing 
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MediSense Soft-Sense  20 sec 1. Alternative site testing 
2. Large memory capacity 
 
 
1.8.4 Bayer HealthCare 
Bayer HealthCare is a health care company of international acknowledgment. The 
Diabetes Care Division is one of the world’s market leaders in the field of blood 
glucose monitoring systems and it markets, under the umbrella brand of Ascenia, 
blood glucose meters (Table 6), test strips and other accessories and services for 
blood glucose monitoring. Bayer acquired its biosensor technology via a Japanese 
alliance with Kyoto Daiichi. It is worthy of note that at the begining of 2003 the 
Diagnostics Division of Bayer HealthCare LLC and Matsushita Electric Industrial Co. 
Ltd. expanded their relationship with the signing of a joint venture agreement and 
establish "Viterion TeleHealthcare LLC", a Bayer-Panasonic company, to market 
products and services for the rapidly growing telehealth market. (4), (56)  
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Table 6:Blood glucose meters by Bayer 
Device Sample  
Volume 
Time Specifications 
Ascenia 
Contour 
0.6 uL 15 sec 1. Alternative site testing 
2. Large memory capacity 
3. No coding required 
Ascenia Elite 2 uL 30 sec 1. 20 tests saving information with dates 
and times 
2. “Sip-in Sampling” 
3. Alternative site testing 
Ascenia Elite 
XL 
2 uL 30 sec 1. 120 tests saving information with dates 
and times 
2. “Sip-in Sampling” 
3. Alternative site testing 
Ascenia 
Breeze 
2.5-3.5 uL 30 sec 1. Large memory capacity 
2. “Autodisc” 
3. Alternative site testing 
4. No coding required 
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1.8.5 Integrated devices 
Pelikan Technologies in Palo Alto, California has developed the first, fully integrated, 
blood sampling and glucose measurement device. It is called Pelikan Sun (Fig.4) 
and based on the company's "one-step, one-button" approach, this lancing device is 
the first fully-automated, electronically-controlled, self-contained system that allows a 
patient to execute the entire lancing process at the touch of a button in a virtually 
painless operation. (57) Unlike existing mechanical lancing devices, the Pelikan Sun 
detects the location of the skin and penetrates to the exact depth without hitting 
sensitive nerves in the finger. In more details the Pelikan Sun lancet rapidly travels 
just to the capillary loops, nicks the capillary loops slightly, makes a soft and 
controlled ‘pillow stop’, and then slowly retracts. The lade’s trajectory is controlled 
and does not jitter, thereby creating a straight wound channel that will not collapse. 
Instead, as the lancet is slowly retracted, blood follows the lancet through the smooth 
wound channel to the surface of the finger. 
It contains a disc of 50 lancets, which is replaced after 50 uses so the person does 
not have to handle the lancets. The Pelikan Sun is ideal for children, frequent 
testers, and people who don’t like the pain of lancing. 
 
Figure 4: Pelikan Sun  
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1.8.6 Alternative Glucose Monitors 
 
The home blood glucose biosensor market is dominated by four large diagnostic 
companies selling “finger-prick” tests which use a tiny sample of capillary blood. 
These companies are continually challenged by new start-ups, which are often the 
engines of change and the most successful, such as MediSense and TheraSense, 
usually end up being acquired by a larger company. The majority of the business of 
these companies in this market is based on single-use mediated amperometric 
biosensor technology. Alternative strategies include minimally invasive testing 
meters and continuous glucose monitoring. 
 
1.8.6a Minimally invasive testing 
The GlucoWatch G2 Biographer (58), (59) is a wrist worn device. It detects trends 
and tracking patterns in glucose levels in adults with diabetes, for use at home and in 
health care facilities. The device obtains automatic measurements of glucose 
concentrations every 20 minutes for up to 12 hours at a time.  It is minimally 
invasive, since the skin is not punctured to obtain a sample. The measurements 
obtained by GlucoWatch are not a substitute for finger-prick blood glucose readings, 
since there is a 20 minute lag between the GlucoWatch monitor and the actual blood 
glucose value, but they can be used for the detection and assessment of episodes of 
hypoglycemia and hyperglycemia, facilitating both acute and long-term therapy 
adjustments. 
 
The device uses reverse iontophoresis to collect glucose samples through intact 
skin. The glucose molecules are collected in a gel collection disk, which contains the 
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glucose oxidase. As glucose enters the disk it reacts with glucose oxidase in the gel 
in order to form hydrogen peroxide. An electrode detects the hydrogen peroxide and 
generates an electronic signal and by the calibration value previously entered by the 
patient, the signal is converted into a glucose measurement, which is displayed on 
the biographer and stored in the memory of the device. 
 
The Glucowatch is produced by Cygnus (Redwood City, CA, USA) and was recently 
acquired by Animas, which was, in turn, acquired by Johnson and Johnson. The 
company does not appear to be actively promoting the device at present following 
some debate about its performance, but is still “supporting” the device in the market. 
 
1.8.6b Continuous Glucose Monitoring System 
Much attention has been given to the development of subcutaneously implantable 
needle-type electrodes, which were first described by Schichiri et al. (60) The sensor 
is presented as a fine needle or flexible wire. The active sensing element, which is 
placed at or near the tip is implanted in the subcutaneous tissue. Such sensors are 
regarded as “minimally invasive” and their subcutaneous implantation avoids the 
problems of sepsis, fouling with blood clot, and embolism, which are potentially 
associated with intravascular placement. The operational lifetime of these devices is 
a few days. 
i) Electrochemical detection of glucose oxidase 
The typical construction of these devices (Fig.5) include the glucose oxidase 
immobilisation at a platinum anode, an inner membrane, such as cellulose acetate, 
which “filters” the interfering substances and an outer membrane, such as 
polyurethane, that controls the diffusion of glucose and improves the 
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biocompatibility. The hydrogen peroxide produced by glucose oxidase is detected 
electrochemically. (61) 
 
 
Figure 5: A typical construction of an electrochemical device to detect glucose 
oxidase (61) 
 
Success in this direction has reached the level of short-term human implantation in 
the hands of Minimed Medtronic (Northridge, CA, USA) and Dexcom (San Diego, 
USA). Such devices could enable a swift and appropriate corrective action through a 
closed-loop insulin delivery system, for example an artificial pancreas. (62) 
Algorithms correcting for the transient difference (time lag) between blood and tissue 
glucose concentrations have been developed. 
 
Medtronic is best known for its implantable devices. It traces its history back 20 
years in diabetes and supports a research program for the development of a 
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continuous glucose sensor as well as an implantable insulin pump. The CGMS 
(Fig.6) is a sensor about the size of an AA battery that transmits radio signals to a 
pager-sized receiver. The device provides up to 288 glucose measurements every 
24 hours, which means 72 times more data than patients testing their blood sugars 
four times a day would obtain. Some patients can obviously benefit from this rich 
source of information, while for others it may be considered simply data overload. 
The CGMS System Gold sensor can measure glucose values up to 72 hours while 
patients go about their normal activities. The CGMS System Gold sensor is typically 
inserted into subcutaneous tissue in the abdominal area and worn for 1 to 3 days. A 
Holter-style monitor stores continuous glucose data measured by the sensor at five-
minute intervals. This data can be downloaded into a computer and reports can be 
easily printed for retrospective analysis. The system uses a needle to insert a very 
narrow guage enzyme electrode beneath the skin, where it encounters interstitial 
fluid. It is designed to be inserted into the subcutaneous tissue, usually in the 
abdominal area, utilising a soft cannula-type device. This diagnostic device is worn 
by the patient for three days and gathers and stores continuous glucose readings 
that can then be downloaded to a personal computer for analysis. The hypoglycemia 
alarm, alerts the patient when the glucose level drops below the limit established by 
the administering physician. (63)  
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Figure 6: CGMS System Gold sensor (63) 
 
Another very similar approach of continuous glucose monitoring has recently been 
established by Dexcom and it is called DexCom STS Continuous Glucose Monitoring 
System (62) (Fig. 7). It is designed for a short term use, as a small insertable or 
implantable device. It presents the property to continuously measure the glucose 
levels and wirelessly to transmit all reading to a small external receiver, the DexCom 
STS. The DexCom STS can also alert the patient when a high or low glucose level is 
detected.  
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Figure 7: DexCom STS Continuous Glucose Monitoring System (62) 
 
ii) Optical detection of glucose oxidase 
In 2004, a novel optical glucosensor has been developed at the University of 
California for continuous monitoring of glucose levels. It is consisted of a fluorescent 
chemical complex, which is immobilised in a biocompatible polymer, permeable to 
glucose. The sensing system is consisted by a fluorescent dye and a quencher, 
which binds to the dye and prevents the fluorescence in the absence of glucose, 
while in the presence of glucose the quencher leads to dissociations of the complex 
and the fluorescence increase. 
The technology has been applied in a marketable product, called GluCath. GluCath 
is a catheter device, used to monitoring blood glucose levels in hospitalised patients. 
It is inserted into a blood vessel and gives a continuous reading and can sound an 
alarm if the glucose level goes too high or too low. Glucose modulates the 
fluorescent signal by binding reversibly to a boronic acid component attached to the 
quencher molecule. The fluorescence is stimulated by light from an LED and can be 
easily measured because it occurs at a distinct wavelength from the LED light (64)  
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A long term, implantable, optical sensor, which designed to provide continuous and 
accurate blood glucose levels, was developed by Animas in 1997. At present, the 
device has been tested over a course of at least two weeks on an in vivo basis in 
dogs. The specific glucosensor is equipped with alarms in order to warn of high and 
low glucose levels and the final goal is the incorporation of an insulin infusion pump 
to provide closed loop control of blood glucose levels. 
The Animas sensor (65) measures the near-infrared absorption of blood and is 
based on spectroscopy. A small display unit about the size of a wrist watch is worn 
on the wrist and the implanted sensor across a vein about the size of a pager 
transmits the reading via radio waves. 
The company is in the progress of designing a miniaturised sensor, which is 
currently undergoing preliminary human trials. (66) 
 
1.9 CHALLENGES AND HURDLES FACING GLUCOSE BIOSENSORS 
 
Over the past forty years there has been intense activity and tremendous progress in 
the development of electrochemical glucose biosensors. Major advances have been 
made to enhance functionality of glucose measuring devices. Despite the impressive 
advances in glucose biosensors, there are still many challenges related to the 
achievement of tight, stable and reliable glycaemic monitoring. Desirable features of 
a biosensor system are accuracy, reliability, ultra sensitivity, fast response and low 
cost per test. It is very important that the biosensor system is user-friendly and 
understood by the patient, thus reducing incorrect results due to human error. This is 
CHAPTER 1 – Introduction and Literature Review 
 
38 
 
one of the reasons that the major companies dealing with glucose monitoring, are 
driving towards the creation of integrated devices. 
 
In US patent 6,497,845 (66)  issued on behalf of Roche, in December of 2002, an 
invention is described including a storage container for holding analytical devices (an 
integrated device). This invention became a commercial product after a couple of 
years with the launch of Accu-Check Compact Plus (67). This device is a blood 
glucose monitoring system based on reflectometric technology. The system consists 
of a meter and dry reagent test strips designed for capillary blood glucose testing by 
people with diabetes or by health care professionals. Compact Plus uses drums with 
17 test strips, and the meter is automatically calibrated by inserting a new drum. An 
electronic check is performed automatically and a test strip is pushed forward when 
the meter is turned on with a button. The system requires a blood volume of 1.5 µL 
and provides a result within 5 seconds. The test principle of Compact Plus relies on 
the reaction of glucose oxidase with pyrroloquinolone quinone (PQQ). An indicator 
changes from yellow to blue by means of a mediator and a redox-process. The blue 
colour is read reflectometrically. The meter has the capacity to store 300 results in 
memory. Accu-Chek Softclix Plus lancet pen is fastened to the Compact Plus meter. 
The lancet pen can be used either when fastened to the meter or it can be taken off 
the meter. 
 
A method and apparatus for handling multiple sensors in a glucose monitoring 
instrument system is  described in US patent 5,510,266 (68) issued in April of 1996, 
in favour of Bayer. The invention is generally related to a glucose monitoring system 
CHAPTER 1 – Introduction and Literature Review 
 
39 
 
and, more particularly, to an improved device for handling multiple sensors that are 
used in analysing blood glucose. This invention became a reality in 2003, with the 
launch of Ascenia Dex, (69) which was the first blood glucose monitor to store 
multiple strips inside the meter. This device was very easy to use and its integration 
reduced incorrect results due to the human error. The integration of the test strips in 
the device was a major innovation, resulting in significant profit to the companies. 
This one of the reasons that these patents became for a subject of litigation between 
Roche and Bayer, since there is an apparent similarity between the drum and the 
disk that Accu-Check Compact and Ascensia Dex have. 
 
Another challenge that glucose biosensors manufacturers had to face is the many 
manual operating steps in conventional lancet systems (lancet and lancing device), 
which is obviously disadvantageous to the user. In most of the systems that are 
available at present, the lancets for use in lancing devices are provided in a loose 
form and for each lancing process, the user manually removes a lancet from a pack 
and has to insert it into the lancet holder of the lancing device and fix it there. 
Numerous attempts to eliminate the above disadvantage have been described. In 
US patent 6,616,616, (70) issued in September 2003, Roche describes an invention 
concerning a lancet system comprising a plurality of essentially needle-shaped 
lancets, a drive unit which has a drive element in order to move the lancet from the 
resting position into the lancing position, a storage area to store the lancets, a 
withdrawal area to guide at least the tip of the lancet out of the system during the 
lancing process and a transport unit which can transport lancets from the storage 
area into the withdrawal area. The above invention became a reality in 2004, with the 
launch of the MultiClix (71). MultiClix is now one of the most popular lancing devices. 
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It is the only one with a six-lancet drum, combining safety and convenience, since no 
handling of lancets is necessary. It also provides 11 penetration depth settings, 
letting the patient adjusting the penetration according to his skin type, reducing by 
this way the pain by avoiding contact with deeper nerves. 
 
If one follows this evolution, then the next logical product is multiple sensors 
combined with multiple lancets as announced by Pelikan Technologies Inc.  This 
presents many technical challenges including achieving sufficiently high density of 
sensing/catalytic sites.  While electrochemical technology has continued to dominate 
this field, one paper by the Pelikan team has explored optical solutions. (72) This 
paper describes a new type of fluorescence-optical glucose biosensor. The 
membrane consisted of an emulsion that incorporated the enzyme glucose oxidase 
capable of catalytically consuming sample glucose and reducing oxygen 
concentration. The emulsion additionally contained an oxygen-quenchable 
fluorescent indicator that produced a signal proportional to the glucose concentration 
in the sample. The particular advantage was seen as a high density array sensor for 
glucose that could be fabricated within the stringent cost restraints associated with 
this market. 
 
1.10 SUMMARY 
 
Diabetes is one of the leading causes of death and disability in the world. 171million 
people in the world are suffering from this disease and several studies have 
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demonstrated the likely increase of this figure to 366 million by 2030. Thus quick 
diagnosis and early prevention are critical for the control of the disease. Forty years 
have passed since Clark and Lyons proposed the concept of glucose enzyme 
electrodes. Since then, excellent economic prospects and fascinating potential for 
basic research have led to many sensor designs and detection principles for the 
biosensing of glucose. 
 
The first-generation of biosensor devices relied on the use of an oxygen co-
substrate, and the production and detection of hydrogen peroxide. Extensive efforts 
during the 1980s were devoted to minimising the error associated with electroactive 
interferences in glucose electrodes. Particularly useful has been the use of artificial 
mediators at the second generation of glucose biosensors. Nowadays commercial 
blood glucose meters are produced by many companies worldwide, but the major 
players are Roche Diagnostics, LifeScan, Abbott and Bayer mostly employ mediated 
amperometric biosensor technology. Some other alternative strategies include 
minimally invasive testing meters and continuous glucose monitoring. As this field 
enters the fifth decade of intense research, the market size and the huge demand is 
creating the need for the development of new approaches, like painless, in vitro 
devices, non-invasive monitoring and miniaturised long term implants with advanced 
biocompatible membranes.  Opportunities for new technology abound and novel 
optical approaches continue to be published. The rigorous demands of 
commercialisation have so far selected in favour of electrochemical devices, but the 
trend towards high density arrays and multi-analytes may yet tip the balance in 
favour of optical techniques such as fluorescence. These and similar developments 
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are expected to greatly improve the control and management of diabetes to the 
overall benefit of the World’s population. 
 
1.11 AIMS & OBJECTIVES 
 
Diabetes is one of the leading causes of death and disability in the world. As this 
field enters the fifth decade of intense research, the market size and the huge 
demand are creating the need for the development of new approaches. Major 
advances have been made to enhance functionality of glucose measuring devices. 
Despite the impressive advances in glucose biosensors, there are still many 
challenges related to the achievement of tight, stable and reliable glycaemic 
monitoring. Desirable features of a biosensor system are accuracy, reliability, ultra 
sensitivity, fast response and low cost per test. 
This project was aimed at better understanding and improve the performance of 
electrochemical glucose biosensors. 
 In general, high surface area electrodes are desired as the high surface area 
provides more active sites for electrochemical reactions, and hence higher 
kinetic rate capability. Therefore, the determination of the active 
electrochemical surface area of the electrode is very important. A study has 
been conducted to determine the real electrochemical surface area of the 
Pelikan SPEs and a method has been optimised and established by Pelikan 
for the evaluation of their SPEs. 
 The haematocrit differences observed in the blood samples can significantly 
affect glucose measurements. Therefore a study has been conducted in order 
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to observe the absorption of the blood samples into the working electrode 
paste according to the haematocrit level 
 A new bi-functional conducting polymer N-(N, N’-diethyldicarbamoyl ethyl 
amido ethyl) aniline (NDDEAEA), incorporating both aniline and 
dithiocarbamate ester groups, which can potentially be used in the 
construction of novel Pelikan electrodes with enhanced integration 
functionalities has been fully characterised and acted as a matrix for the 
development of an amperometric glucose biosensor. This material is capable 
of grafting protective anti-adhensive layers to assure that the poor 
performance in sensors as a result of impact of blood components can be 
mitigated. 
 The purpose of this study was to develop and optimise the reaction conditions 
to grafting a hyperbranched polymer onto the surface of the multi-walled 
carbon nanotubes (MWCNT), using the A3 + B2 approach. By this study we 
aimed to explore a further advanced approach to significantly increase the 
sensitivity of Pelikan SPEs. 
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2.1 PELIKAN SUN: A COMMERCIAL AMPEROMETRIC GLUCOSE OXIDASE 
BIOSENSOR 
 
2.1.1 MATERIALS 
Chemicals: 
The TMPD (N,N,N',N'-Tetramethyl-p-phenylenediamine, CAS No:100-22-1), was 
purchased from Acros-Organics (Geel, Belgium). The 2-(1-Methoxy)propyl Acetate 
97%, used as diluter for preparing stock solutions of TMPD, was purchased from 
Acros-Organics (Geel, Belgium). All the reagents used to make the buffers 
(Phosphate Buffer Saline) were purchase from Sigma-Aldrich (Dorset-UK). 
Deionised water was used for all solution preparations. All solutions used to perform 
the electrochemical experiments were freshly prepared and degassed by bubbling 
pure nitrogen. The blood samples were purchased by Sera laboratories International 
and stored at 4o C. The working electrode paste was supplied from Pelikan 
Technologies GmbH (Munster, Germany). The glass microscope slides used to 
deposit the working electrode paste were purchased from VWR International LTD 
(Lutterworth, UK). 
 
Electrodes: 
The cyclic voltammograms and the chronocoulometric plots were obtained by using 
either a 10mL three-electrode cell, or Pelikan screen-printed electrodes. The three-
electrode cell includes a glassy carbon working electrode (1.6 mm diameter), a 
platinum wire counter electrode and a Ag/AgCl reference electrode, purchased from 
BASi Electrochemistry Instruments (Warwickshire, UK). The Acheson and Dupont 
screen-printed electrodes, as well as the Pelikan screen-printed electrodes were 
CHAPTER 2 – Materials & Methods 
 
46 
 
supplied by Pelikan Technologies GmbH (Munster, Germany). The geometrical 
surface area of all of those screen printed electrodes is 0.25mm2. 
 
Apparatus: 
All of the electrochemical experiments (cyclic voltammetry and chronocoulometry) 
were performed using either a µ-Autolab type III potentiostat (Eco Chemie, 
Netherlands) with the GPES software, or a PG580 potentiostat-galvanostat 
(Uniscan, UK) with the UiEChem™ software. All data were transferred and analysed 
by Microsoft Office Excel, on a personal computer. The final data included in this 
report are the mean of the measurements in triplicate. In order to perform the 
experiment with the contact angle goniometer the CAM 100 series (KSV 
Instruments, Finland) contact angle goniometer was used. 
 
2.1.2 METHODS  
 
i) Cyclic voltammetry (CV) 
Cyclic voltammetry (73) falls into a class of potentiodynamic experimental methods. 
Due to the increasing development of computer controlled equipment with 
automated data collection and due to the development of mathematical description 
of potentiodynamic curves these experimental methods have expanded into 
laboratory practise widely in the last few decades. Nowadays these techniques 
enable the user to obtain the basic characteristics of the studied system regarding 
mainly a mechanism of electrode reactions and their kinetic parameters in relatively 
short period of time. 
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Cyclic voltammetry is characterised by smooth increase of a working electrode 
potential from one potential limit to the other and back. It follows that the potential 
limits and the potential sweep rate are the basic adjustable parameters. Also the 
properties of an electrolyte, mainly the concentration of electroactive species and 
temperature, could be affected. 
The system response is then named polarisation (Figure 8) or dependence of current 
flowing through an electrode on its potential. This curve is sometimes also assigned 
as an electrochemical spectrum of the studied system. 
 
 
Figure 8 Potentiodynamic Polarisation Curve 
 
 Generally two limiting cases of studied systems do exist, the reversible electrode 
process and the irreversible electrode process. 
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Reversible electrode reactions: 
One current peak on the potentiodynamic polarisation curve corresponds to every 
electrode reaction. If the equilibrium potentials of these reactions are close to each 
other the peaks corresponding to these reactions could overlap. Each peak could be 
characterised by several basic data. The potential (Ep) and current (Ip) of the peak, a 
half-wave potential (E1/2 when I=Id/2) and a potential at the half of the peak (Ep/2 
when I=Ip/2). ( Figure 9) 
 
 
Figure 9 Illustration of the current density of a peak  
 
For a reversible electrode reaction the surface concentration of electroactive species 
in every point of polarisation curve must correspond to the Nernst equation (equation 
1) 
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Where: 
E: electrode potential 
R: universal gas constant 
T: temperature 
F: Faraday’s constant 
n: number of electrons exchanged within electrode reaction 
Co: molar concentration of oxidised species 
Cr: molar concentration of reduced species 
 
Meanwhile the dependence of electrode potential on time could be presented in the 
case of potentiodynamic methods by the equation (2): 
  (Eq 2) 
 
By substituting E in Nernst equation a dependence of ratio of surface concentration 
of oxidized and reduced species on time and on potential sweep rate could be 
expressed: 
 
  (Eq 3) 
 
Thus in a general potentiodynamic polarisation, the peak current (Ip) could be 
obtained from the following equation: 
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  (Eq 4) 
Where: 
I: current  
n: number of electrons exchanged within electrode reaction 
F: Faraday’s constant 
Co: molar concentration of oxidised species 
R: universal gas constant 
T: temperature 
v: potential sweep rate 
Do: diffusion coefficient of oxidised species 
 
Since the above equation only reflects the value of half-peak potential, the difference 
between a peak potential and half-peak potential are govern by the below equations: 
 
  (Eqs 5 & 6) 
 
It is worth noting the peak potential and other potential characteristics are sweep-
rate independent and the peak current density is directly proportional to v1/2, when 
the reaction is reversible. Hence these equations can be used to determine the 
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number of electrons exchanged within the electrode reaction or for the determination 
of diffusion coefficients of electroactive species. (73) 
 
Irreversible electrode reactions 
In comparison for a fully reversible electrode reaction the boundary condition on the 
surface of an electrode is determined by the kinetics of electrode raction rather than 
the Nernst equilibrium: 
 
  (Eq 7) 
Where: 
I: current density 
n: number of electrons exchanged within electrode reaction 
F: Faraday’s constant 
A: surface area of the electrode  
D: diffusion coefficient 
d: diffusion limited variable (Id diffusion current) 
k:  kinetic constant 
 
The value of its kinetic constant is given by: 
 
  (Eq 8) 
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By integrating the above two equations the peak current density could be described 
by: 
  (Eq 9) 
 
Since the above equation only reflects the value of half-peak potential (E1/2), the 
value of a whole peak potential (Ep/) and the distance between Ep and E1/2 could be 
calculated by using the following equations, respectively 
(Eqs 10 & 11) 
On the basis of these equations the peak current density is directly proportional to 
the square root of potential sweep rate in the case of irreversible electrode reaction. 
The fact that the peak potential is a function of potential sweep rate, specifically it is 
directly proportional to its square root, represents, however, a significant difference 
from reversible process. 
 
Therefore the cyclic voltammograms provide a useful platform for the 
characterization and mechanistic studies of redox reactions at electrodes. 
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ii) Chronocoulometry (CC) 
Chronocoulometry is another electrochemical technique frequently used in 
electroanalytical chemistry (74). It is the measurement of charge as a function of 
time. Applications of this technique include measurement of electrode surface area, 
diffusion coefficients, the time window of an electrochemical cell, adsorption of 
electroactive species and the mechanisms and rate constants for chemical reactions 
coupled to electron transfer reaction. The effects of changes in potential used in the 
CC experiment can be understood by considering the Nernst Equation which relates 
the applied potential, the formal redox potential (EO) and the surface concentrations 
(CS) of the relevant electroactive species. For the redox couple O+ne-=R, the Nernst 
Equation is: 
 = 
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+
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  (Eq 12) 
Where: 
n = number of electrons transferred  
 
The analysis of the chronocoulometric data is based on the Anson equation, which 
defines the charge-time dependence for linear diffusion control: 
Q = 2nFACD½π-½t ½   (Eq 13) 
 
Where: 
Q: charge (coulombs) 
CHAPTER 2 – Materials & Methods 
 
54 
 
n: number of electrons transferred 
A: real electrochemical surface area of the electrode (cm2) 
F: Faraday’s constant (96,485 coulombs/mole) 
C: the concentration of the mediator 
D: diffusion coefficient of the mediator (cm2/sec) 
t: time (sec) 
 
A plot of Q vs. t½ is often referred as the Anson plot (75) The Anson plot transforms 
the data into a linear relationship whose slope (a) is equal to: 
2nAFCD1/2/π1/2     (Eq. 14) 
By using the above equation the real electrochemical surface area of the electrode is 
thus able to be determined. 
 
iii) Standard addition method 
Standard addition method is an analytical method which relies on the fact that the 
analytical signal is proportional to the analyte concentration. In our case it is well 
known that the electrical current of an electrochemical process is proportional to the 
concentration of the analyte used. The stadard addition equation is: 
CX = [(AX CS VS) / VX] / [AX+S((VX+VS)/VX) - AX] (Eq. 15) 
 
Where: 
Cx: standard concentration of the unknown 
Ax: analytical signal of the unknown 
Cs: standard concentration 
Vs: standard volume 
Vx: volume of the unknown 
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Ax+s: analytical signal of unknown plus standard 
 
iv) Methodology followed for determing the real electrochemical surface area 
of the electrodes 
 
The determination of the real surface area of the working electrode is mainly based 
on the use of Chronocoulometry (Figure 10). (A detailed SOP-Standard Operational 
Procedure- can be found in the Appendix) It is the measurement of charge as a 
function of time. The analysis of the chronocoulometric data is based on the Anson 
equation, which defines the charge-time dependence for linear diffusion control: 
Q = 2nFACD½π-½t -½ 
 
A plot of Q vs. t½ is often referred as the Anson plot which transforms the data into a 
linear relationship whose slope (a) is equal to the following equation: 
a = 2nAFCD1/2/π1/2 
Where: 
n: number of electrons transferred 
A: real electrochemical surface area of the electrode (cm2) 
F: Faraday’s constant (96,485 coulombs/mole) 
C: the concentration of the mediator (mol/cm3) 
D: diffusion coefficient of the mediator (cm2/sec) 
 
By using the above equation the real electrochemical surface area (A) of the working 
electrode (cm2) can be calculated providing the concentration (C) and the diffusion 
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coefficient of the mediator (D) incorporated in the working electrode paste are 
known.  
Diffusion coefficient 
The diffusion coefficient of the mediator can be determined by Cyclic Voltammetry. 
By immersing the electrode in PBS, the cyclic voltammograms were run with three 
different scan rates (10mV/sec, 25mV/sec, 50mV/sec), respectively. Three oxidation 
peak currents (Eox) were then plotted against the square root of the scan rates. The 
resulting slope of the plot is equal to the diffusion coefficient of the mediator. 
 
Concentration of the mediator 
The standard addition method was applied to calculate the concentration of the 
mediator present in the electrodes. In our case it is well known that the electrical 
current of an electrochemical process is proportional to the concentration of the 
analyte used. 
 
N,N,N',N'-tetramethyl-p-phenylendiamine (TMPD) is used by Pelikan as the mediator 
which is incorporated in the working electrode paste. TMPD presents two well 
defined one-electron oxidations. The first oxidation is reversible and can be cycled 
indefinitely. The second oxidation is rendered irreversible by a following chemical 
reaction probably related to the hydrolysis of the electrochemical product. In this 
study we focused on the initial one electron reversible process. (76), (77)  Five 
TMPD solutions with different concentrations in PBS were prepared and the cyclic 
voltammograms were obtained by using the Pelikan electrode. However, the 
electrochemical response attributes to both of the mediator in PBS and the mediator 
incorporated in the working electrode (WE) paste. In order to observe the 
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electrochemical response of the mediator incorporated in the WE paste, cyclic 
voltammograms was run in PBS only. The oxidation peak currents observed in the 
cyclic voltammograms were then plotted against the concentration of the added 
mediator. Linear regression is performed and the slope and intercept of the 
calibration curve are used to calculate the unknown concentration of the mediator 
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Figure 10 Schematic representation of the determination of the real electrochemical 
surface area 
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v) Haematocrit effect - Absorption of the blood sample into the working 
electrode paste according to the haematocrit levels 
 
A goniometer was used in order to observe the absorption of the whole blood 
samples in the working electrode paste, in accordance with the heamatocrit levels. 
Contact angle measurements have been recorded between the WE paste and the 
different blood samples with different heamatocrit levels, for 16 seconds with frame 
intervals of 2 seconds. The heamatocrit range tested was between 25 to 40 per cent. 
In order to avoid the blood sample variation, just one blood sample has been used to 
run the experiment. The initial hematocrit level was 40% and in order to obtain blood 
samples with different heamatocrit levels, the initial blood sample was diluted further 
using physiological saline (0.9% NaCl). 
 
2.2 AN AMPEROMETRIC GLUCOSE OXIDASE BIOSENSOR USING AN 
ELECTROCHEMICALLY GENERATED CONDUCTING POLYMER 
 
2.2.1 MATERIALS 
Chemicals: 
All the chemicals and solvents used within this work were purchased from Sigma-
Aldrich (Dorset, UK) and were of Analytical grade. The NDDEAEA was synthesized 
and supplied by Mrs Petya Iwanova-Mitseva. All solutions used to perform the 
electrochemical experiments, including the monomer solution, were freshly prepared 
and degassed by bubbling pure nitrogen. Glucose solutions were freshly prepared 
the day before each experiment in order to allow muta-rotation of the isomers and 
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were kept at 4oC. Glucose oxidase from aspergillus niger, type II-S, 15,000-50,000 
units/g solids was purchased from Sigma Aldrich (Dorset, U.K.) and was stored at -
20oC when not in use. The screen printed gold electrodes (SPE) (1.6 mm diameter) 
were purchased from Dropsens. 
 
Apparatus: 
All of the electrochemical experiments were performed using either a µ-Autolab 
type III potentiostat (Eco Chemie, Netherlands) with the GPES software. All data 
were transferred and analysed by Microsoft Office Excel, on a personal computer. 
The final data included in this report are the mean of the measurements in triplicate. 
A Philips UV lamp (8m Wcm2) and a fiber optic light source with a 0.016 W/cm2 
intensity CERMAX® Xenon Arc Lamp (Perkin-Elmer Optoelectronics, Inc., USA) 
were used to irradiate the samples. Sessile water contact angle measurements were 
made using Cam 100 optical Angle Meter (KSV Instruments Ltd., Finland) with the 
software provided. Atomic Force Microscopy was performed using the DI 3000 digital 
instrument, while the Scanning Electron Microscopy was performed using the FEI 
XL300 SFEG (Scanning Field Emission Gun). 
 
2.2.2 METHODS  
i) Electrochemical Polymerisation of NDDEAEA 
Before use every new electrode was cleaned and pre-treated by potential cyclic by 
CV from 0 to + 0.7 V, 5 times cycling, 50 mV/S scan rate in 1.5 M HCl. The stock 
solution of the monomer was prepared by adding 68 mg of NDDEAEA (0.2 M 
NDDEAEA, MW 339.52) in a 5 ml beaker in the presence of 250 µL of acetonitrile 
and 750 µL of 0.75 M HCl. Solution was mixed well and degassed for 10 minutes by 
CHAPTER 2 – Materials & Methods 
 
61 
 
purging Ar/Nitrogen and covered by aluminum foil to protect from light. CV 
measurements were performed by placing 50 µL of the test solution of NDDEAEA 
onto the surface of SPE for electropolymerisation. Electrodes were cycled between   
-0.2 V and +0.9 V at a scan rate of 100mV /s, (step potential 7 mV) (up to 20 scans, 
for optimal polymer thickness). Electropolymerisation was carried out under Ar 
atmosphere and dark condition. Electropolymerised films were rinsed with deionised 
water (once), dried in a stream of nitrogen and kept dried in dark. 
 
ii) Iniferter-activation and photocrosslinking of electropolymerised films of 
NDDEAEA 
The electropolymerised film of NDDEAEA, formed on screen printed gold electrode, 
was treated with a solution of supporting electrolyte/acetonitrile/ HCl and oxygen was 
removed by purging pure Nitrogen for 10 minutes. The film was then irradiated for 5-
15 minutes through the solution using a fibre optic UV lamp mounted at 8 cm from 
the sample to activate the iniferter part of NDDEAEA and generate dithiocarbamate 
radicals. The film was then rinsed in a stream of 50% methanol and deionised water 
and dried in a stream of nitrogen. 
 
Photografting of poly (methacrylic acid) to an electropolymerised film of NDDEAEA: 
An electropolymerised film of NDDEAEA was treated with a solution of methacrylic 
acid (0.1 M in acetonitrile). The solution was degassed with argon for 10 minutes 
before irradiation with UV for 15 minutes. The passage of argon was continued at a 
low flow rate during the polymerisation period. The electrode was recovered and the 
polymer surface was rinsed in a stream of 50% methanol and deionised water and 
dried in a stream of nitrogen and stored for further use. 
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Photografting of poly (AMPSA) to an electropolymerised film of NDDEAEA: 
An electropolymerised film of NDDEAEA was immersed in a solution of AMPSA (0.1 
M in acetonitrile). The solution was degassed with argon for 10 minutes before 
irradiation with UV for 15 minutes. The passage of argon was continued at a low flow 
rate during the polymerisation period. The electrode was recovered and the polymer 
surface was rinsed in a stream of 50% methanol and deionised water and dried in a 
stream of nitrogen. 
 
Photografting of poly (Styrene) to an electropolymerised film of NDDEAEA:  
An electropolymerised film of NDDEAEA was immersed in a solution of styrene (0.1 
M in acetonitrile). The solution was degassed with argon for 10 minutes before 
irradiation with UV for 15 minutes. The passage of argon was continued at a low flow 
rate during the polymerisation period. The electrode was recovered and the polymer 
surface was rinsed in a stream of 50% methanol and deionised water and dried in a 
stream of nitrogen. 
 
Layer-by-layer consecutive photografting of poly (styrene) over poly (MAA) layer 
grafted to an electropolymerized film of poly (NDDEAEA).  
To prove the living nature of the dithiocarbamate ester groups of poly (NDDEAEA), 
activated during UV irradiation, consecutive layer-by-layer grafting of solutions of two 
different monomers, viz., MAA followed by styrene, were performed. For the layer-
by-layer grafting experiment, a poly(MAA) grafted SPE electrode, prepared as 
described in part a) above, was treated with a solution of styrene (50 µL of 0.1 M in 
acetonitrile) as described in the previous part.  
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iii) Glucose Oxidase immobilisation 
As we mentioned earlier when the poly(NDDEAEA)-modified electrode in 0.75 M HCl 
was irradiated with UV light, dormant DTC radicals and active carbon centred 
radicals, have been created. This property has been used in order to immobilise the 
glucose oxidase in the specific glucose biosensor. After the monomer being 
electropolymerised by the method described above, UV light is applied on the 
electropolymerised electrode, after covering it with 150 µL of GOX (30 mg/mL), for 
15min. The obtained electrode was rinsed with DI water, dried carefully with Nitrogen 
and stored in a dark container. For calibration and characterization of glucose sensor 
a 5 ml of pH 7.5 phosphate buffer was placed in a container and all the 
measurements were carried out after the background current was stabilized, and 
consecutive additions of 0.1 ml of 0.5 M of glucose were added to the solution.  
 
2.3 DEVELOPMENT AND OPTIMISATION OF THE REACTION CONDITIONS TO 
GRAFTING HYPERBRANCHED POLYMER ONTO THE SURFACE OF THE 
MULTIWALL CARBON NANOTUBES 
 
2.3.1 MATERIALS 
Chemicals: 
Multi-walled carbon nanotubes (with length 20 µm, external diameter 10-20 nm and 
surface area> 350m2/g) were purchased from Arry International (Germany). 1,1′-
Ferrocenedicarboxaldehyde, Tris(2-aminoethyl)amine, Sodium cyanoborohydride, 
Thionyl chloride, Tetrahydrofuran anhydrous, ≥99.9%, inhibitor-free, 
triphenylphosphit and pyridine were purchased from Sigma-Aldrich (Dosret, UK). 
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Apparatus: 
Scanning Electron Microscopy was performed using the FEI XL300 SFEG (Scanning 
Field Emission Gun). 
 
2.3.2 METHODS  
 
i) Grafting of Hyperbranched polymer onto MWCNTs using A3 & B2 monomers  
Protocol A1 of the First Approach: 
The aminated MWCNTs (10wt%) were introduced in the ultrasonic bath for 15 
minutes in the presence of 100 mL of dried ethanol. The A3 (1,1′-
Ferrocenedicarboxaldehyde) and B2 (Tris(2-aminoethyl)amine) monomers (molar 
ratio 1:1) were added and stirred at room temperature for 30 minutes. After they 
were refluxed for 8 hours at 80 oC, they were let to cool down at room temperature. 
The reduction step was then followed by adding a 2.5eq. of sodium borohydride. 
Finally the mixture was submitted to vigorous stirring for 24 hours. The product was 
collected by suction filtration, using a 0.22µm polycarbonate membrane and further 
Soxhlet extracted in tetrahydrofuran for 24 hours at 66 oC. The final product was 
dried in the vacuum oven at 40oC for 24 hours. 
 
Protocol A2 of the First Approach: 
The aminated MWCNTs (10wt%) were introduced in the ultrasonic bath for 15 
minutes in the presence of 100mL of dried ethanol. The A3 (1,1′-
Ferrocenedicarboxaldehyde) and B2 (Tris(2-aminoethyl)amine) monomers (molar 
ratio 1:1) were added and stirred at room temperature for 30 minutes. After they 
were refluxed for 24 hours at 80 oC, they were let to cool down at room 
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temperature. The reduction step was followed adding a 2.5eq. of sodium 
borohydride. Finally the mixture was submitted to vigorous stirring for 24 hours. The 
product was collected by suction filtration, using a 0.22µm polycarbonate membrane 
and further Soxhlet extracted in tetrahydrofuran for 24 hours at 66 oC. The final 
product was dried in the vacuum oven at 40oC for 24 hours. 
 
Protocol B1 of the Second Approach : 
The aminated MWCNTs (10wt%) were introduced in the ultrasonic bath for 15 
minutes in the presence of 100mL of N-Methyl-2-pyrrolidon. 30mM of B2 (Tris(2-
aminoethyl)amine) monomer was mixed with two catalysts:  the triphenylphosphit 
and the pyridine in a concentration 10 times higher than the concentration of the 
monomer and refluxed at 90 oC for 1 hour. After the addition of 30mM of A3 (1,1′-
Ferrocenedicarboxaldehyde) monomer and calcium chloride, in a 3 times higher 
concentration of the starting material, the mixture was allowed to reflux at 90 oC for 8 
hours. The product was collected by suction filtration, using a 0.22µm polycarbonate 
membrane and further Soxhlet extracted in tetrahydrofuran for 24 hours at 66 oC. 
The final product was dried in the vacuum oven at 40oC for 24 hours. 
 
Protocol B2 of the Second Approach: 
The aminated MWCNTs (10wt%) were introduced in the ultrasonic bath for 15 
minutes in the presence of 100mL of N-Methyl-2-pyrrolidon. 30mM of B2 (Tris(2-
aminoethyl)amine) monomer was mixed with two catalysts:  the triphenylphosphit 
and the pyridine in a concentration 10 times higher than the concentration of the 
monomer and refluxed at 90 oC for 1 hour. After the addition of 30mM of A3 (1,1′-
Ferrocenedicarboxaldehyde) monomer and calcium chloride, in a 3 times higher 
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concentration of the starting material, the mixture was allowed to reflux at 90 oC for 
24 hours. The product was collected by suction filtration, using a 0.22µm 
polycarbonate membrane and further Soxhlet extracted in tetrahydrofuran for 24 
hours at 66 oC. The final product was dried in the vacuum oven at 40oC for 24 hours. 
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3RD CHAPTER 
RESULTS 
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3.1 PELIKAN SUN: A COMMERCIAL AMPEROMETRIC GLUCOSE OXIDASE 
BIOSENSOR 
 
3.1.1 DETERMINATION OF THE REAL ELECTROCHEMICAL SURFACE AREA 
OF THE ELECTRODES 
 
The research aimed at optimisation of the performance of Pelikan sensors involved 
two parts: analysis of surface area of the electrodes and study of the impact of 
haematocrit effects on sensor performance. 
 
i) Determination of the real electrochemical surface area of a glassy carbon 
electrode 
As can been seen in Figure 11a, 11b and 11c the cyclic voltammograms of 0.5mM, 
1mM and 2mM TMPD were recorded respectively in 0.1M Phosphate buffer, pH 7.4, 
containing 0.154M NaCl as a supporting electrolyte, at a 10mL three-electrode cell, 
with a glassy carbon working electrode, a platinum wire counter electrode and a 
Ag/AgCl reference electrode. The applied scan rates were 10, 25 and 50mV per 
second.  
 
The resulting diffusion coefficients are presented in Figure 12 with respect to the 
different concentrations of the mediator (TMPD). It was observed that by increasing 
the concentration of the mediator in the solution, the diffusion coefficient increased. 
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Figure 11a: Cyclic Voltammograms of 0.5mM TMPD in 0.1M Phosphate buffer, pH 
7.4, containing 0.154M NaCl as a supporting electrolyte, at a 10mL three-electrode 
cell, with a glassy carbon working electrode, a platinum wire counter electrode and a 
Ag/AgCl reference electrode. 
 
 
 
 
Figure 11b Cyclic Voltammograms of 1mM TMPD in 0.1M Phosphate buffer, pH 7.4, 
containing 0.154M NaCl as a supporting electrolyte, at a 10mL three-electrode cell, 
with a glassy carbon working electrode, a platinum wire counter electrode and a 
Ag/AgCl reference electrode. 
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Figure 11c Cyclic Voltammograms of 2mM TMPD in 0.1M Phosphate buffer, pH 7.4, 
containing 0.154M NaCl as a supporting electrolyte, at a 10mL three-electrode cell, 
with a glassy carbon working electrode, a platinum wire counter electrode and a 
Ag/AgCl reference electrode. 
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Figure 12 Diffusion coefficients (D) of the mediator (TMPD) with different 
concentration (0.5mM, 1mM and 2mM) 
 
The results of chronocoulometry are presented in Figure 13.  The total charge 
passed of 0.5, 1 and 2mM TMPD versus time were recorded using the glassy carbon 
electrode. The measurement was conducted after dipping the electrodes in 10mL 
TMPD solution. The pulse width was 2sec. 
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scan rates √scan 
rate 
Eox 
(0.5mM 
TMPD) 
Eox 
(1mM 
TMPD) 
Eox 
(2mM 
TMPD) 
10mV/sec 3.162 2.33E-06 7.73E-06 1.46E-05 
25mV/sec 5 3.71E-06 1.20E-05 2.34E-05 
50mV/sec 7.072 5.34E-06 1.64E-05 3.42E-05 
D  7.709E-07 2.219E-06 4.998E-06 
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Figure 13 The chronocoulometric results of 0.5mM, 1mM and 2mM TMPD using the 
glassy carbon electrode (No of Steps: 2, EIN: -0.20V, EFIN: 0.2V, Duration: 4sec, Pulse 
Width: 2sec) 
 
 
The following Anson plots are shown in Figure 14. By using the Anson equation, the 
real electrochemical surface area of the glassy carbon electrode was able to be 
calculated (Table 7) as described previously in the part of methods. 
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Figure 14 Anson plot – forward step (glassy carbon electrode) 
 
It was further found that the real electrochemical surface area of the glassy carbon 
electrode decreased along with the increasing concentration of mediator TMPD in 
the solution. On the contrary, the diffusion coefficient increased by enhancing the 
concentration of the TMPD. 
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Table 7 Real electrochemical surface area of the glassy carbon electrode 
 
REPLICATES slope C 
(mol/cm3) 
D A  
(mm2) 
 
0.5mM#1 9.42E-06 0.0000005 7.10E-07 20.53  
0.5mM#2 9.61E-06 0.0000005 7.10E-07 20.94  
0.5mM#3 9.59E-06 0.0000005 7.10E-07 20.90  
       20.79 AVERAGE 
       0.22 STDEV 
       1.09 CV% 
1mM#1 2.64E-05 0.000001 2.22E-06 16.27  
1mM#2 3.03E-05 0.000001 2.22E-06 18.67  
1mM#3 3.00E-05 0.000001 2.22E-06 18.48  
       17.81 AVERAGE 
       0.13 STDEV 
       0.70 CV% 
2mM#1 5.81E-05 0.000002 5.00E-06 11.93  
2mM#2 5.78E-05 0.000002 5.00E-06 11.86  
2mM#3 5.80E-05 0.000002 5.00E-06 11.90  
    11.90 AVERAGE 
    0.03 STDEV 
    0.26 CV% 
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ii) Determination of the real electrochemical surface area of Acheson and 
Dupont SPE. 
 
The Acheson and Dupont electrodes present the same dimensions with the Pelikan 
screen printed electrodes. The only major difference is that their working electrode 
paste was made of carbon paste. In contrast, the working electrode paste used for 
Pelikan screen printed electrodes is a complex matrix containing carbon paste, 
enzyme (glucose oxidase), mediator (TMPD) and several buffers. The studies on 
Acheson and Dupont screen printed electrodes were therefore designed to generate 
some preliminary results excluding the effect of other elements, such as mediator 
and enzyme. 
 
The cyclic voltammograms of three replicates, recorded for 100µM TMPD in 0.1M 
Phosphate buffer, pH 7.4, containing 0.154M NaCl as a supporting electrolyte, at the 
Acheson screen printed electrodes are presented in Figure 15. The scan rates 
applied were 10, 25 and 50mV per second.  
 
The diffusion coefficients of the mediator using the Acheson screen printed 
electrodes are presented in Table 8. It was calculated that the diffusion coefficient of 
the mediator is 6.519E-06 cm2/sec. 
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Figure 15 The cyclic voltammograms of three replicates, recorded for 100µM TMPD 
in 0.1M Phosphate buffer, pH 7.4, containing 0.154M NaCl as a supporting 
electrolyte, at the Acheson screen printed electrodes. The scan rates applied were 
10, 25 and 50mV per second 
 
Table 8 Diffusion Coefficient of TMPD on the Acheson Electrodes 
 
Scan rates √scan rate Eox I Eox II Eox III   
10mv/sec 3.162 2.07E-05 1.86E-05 2.07E-05   
25mV/sec 5.000 3.17E-05 3.18E-05 3.15E-05   
50mV/sec 7.071 4.36E-05 4.83E-05 4.44E-05   
D  5.867E-06 7.616E-06 6.073E-06 6.519E-06 AVR 
     9.554E-07 STD 
     14.656 CV % 
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Figure 16 shows the chronocoulometric response, the total charge passed versus 
time of 100µM of TMPD recorded on the Acheson screen printed electrode. The 
measurement occurred after applying on the electrodes 0.7µL solution of 100µM 
TMPD. The pulse width was 2sec. 
 
 
 
Figure 16 Chronocoulometric Plot (Acheson electrodes) (No of Steps: 2, EIN: -0.20V, 
EFIN: 0.2V, Duration: 4sec, Pulse Width: 2sec) 
 
Anson plot is represented in Figure 17. By using the Anson equation described 
above the real electrochemical surface area of the Acheson screen printed electrode 
was calculated. The results are shown in table 9. The real electrochemical surface 
area of the Acheson screen printed electrodes is approximately 178.71 mm2. 
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Figure 17 Anson Plot – forward step- (Acheson electrodes) 
 
Table 9 Real electrochemical surface area of the Acheson Electrodes 
 
REPLICATES slope C (mol/cm3) D A (mm2)  
#1 4.66E-05 1E-07 6.52E-06 167.525  
#2 5.16E-05 1E-07 6.52E-06 185.569  
#3 5.09E-05 1E-07 6.52E-06 183.056  
    178.71 AVR 
    9.773 STD 
    5.468 CV % 
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Dupont screen printed electrodes are presented in Figure 18. The scan rates applied 
were 10, 25 and 50mV per second.  
 
 
 
Figure 18The cyclic voltammograms of three replicates, recorded for 100µM TMPD 
in 0.1M Phosphate buffer, pH 7.4, containing 0.154M NaCl as a supporting 
electrolyte, at the Dupont screen printed electrodes. The scan rates applied were 10, 
25 and 50mV per second 
 
The diffusion coefficient of the mediator on the Dupont screen printed electrodes is 
presented in table 10. It was calculated that the diffusion coefficient of the mediator 
is 7.859E-06 cm2/sec. 
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Table 10 Diffusion Coefficient of TMPD on the Dupont Electrodes 
 
scan rates √scan rate Eox I Eox II Eox III   
10mv/sec 3.162 1.23E-05 1.26E-05 1.58E-05   
25mV/sec 5.000 2.89E-05 3.12E-05 2.89E-05   
50mV/sec 7.071 4.52E-05 4.19E-05 4.60E-05   
D  8.406E-06 7.428E-06 7.742E-06 7.859E-06 AVR 
     4.995E-07 STD 
     6.356 CV% 
 
Figure 19 shows the chronocoulometric response, the total charge passed versus 
time of 100µM of TMPD recorded on the Dupont screen printed electrode. The 
measurement occurred after applying on the electrodes 0.7µL solution of 100µM 
TMPD. The pulse width was 2sec. 
 
 
Figure 19 Chronocoulometric Plot (Dupont electrodes) (No of Steps: 2, EIN: -0.20V, 
EFIN: 0.2V, Duration: 4sec, Pulse Width: 2sec) 
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The Anson plot is represented in Figure 20. By using the Anson equation described 
above the real electrochemical surface area of the Dupont screen printed electrode 
was calculated. The results are shown in table 11. The real electrochemical surface 
area of the Dupont screen printed electrodes is approximately 175.87 mm2. 
 
 
 
Figure 20 Anson Plot –forward step- (Dupont electrodes) 
 
Table 11 Real electrochemical surface area of the Dupont Electrodes 
 
REPLICATES slope C (mol/cm3) D A (mm2)  
#1 5.50E-05 0.0000001 7.859E-06 180.130  
#2 5.20E-05 0.0000001 7.859E-06 170.304  
#3 5.41E-05 0.0000001 7.859E-06 177.182  
    175.87 AVR 
    5.041 STD 
    2.866 CV % 
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The major limitation using chronocoulometry (CC) as has already been mentioned, is 
the fact that CC relies on the Anson equation which defines the charge time 
dependence for linear diffusion controlled environments. Our experiment using the 
Acheson and Dupont electrodes do not rely on diffusion controlled environments, 
since the cyclic voltammograms obtained show irreversible reactions (the separation 
peak currents are greater than 59mV/electron). The overall results obtained are not 
conclusive. 
 
iii) Determination of the real electrochemical surface area of Pelikan SPE 
 
Five TMPD solutions with different concentrations in PBS were prepared and used to 
run cyclic voltammetry. However, the electrochemical response attributes to both of 
the mediator in PBS and the mediator incorporated in the working electrode (WE) 
paste. In order to observe the electrochemical response of the mediator incorporated 
in the WE paste, cyclic voltammograms was also run in PBS only. The oxidation 
peak currents observed in the cyclic voltammograms (Figure 21) were then plotted 
against the concentration of the added mediator. The concentration of the TMPD can 
be calculated from the slope and intercept of the standard addition calibration curve. 
(Figure 22) 
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Figure 21 Cyclic Voltammograms on Pelikan electrodes 
 
 
Figure 22 Standard addition calibration curve 
 
iv) Evaluation method for pelikan SPE 
There are in total 15 different batches of screen printed electrodes supplied by 
Pelikan. The WE paste of six of these electrodes was prepared by a ball mill. The 
real electrochemical surface area of these electrodes was calculated using 
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Chronocoulometry, after determing initially the unknown concentration of the 
mediator incorporated in the working electrode paste and the diffusion coefficient. 
The detailed results are presented on the Table 12. The concentration of the 
mediator incorporated in the working electrode paste ranges from 1.92mM to 
4.59mM, while the diffusion coefficient ranges from 3.28e-08 cm2/sec to 1.06e-07 
cm2/sec. By using the Anson equation described above the real electrochemical 
surface area of each sensor was calculated.  
It was observed that there is a close relation among the concentration of the 
mediator, the diffusion coefficient and the real electrochemical surface area of these 
electrodes. As similar to the previous experiment performed applying the glassy 
carbon working electrode, the real electrochemical surface area of these screen 
printed electrodes decreased along with the increasing concentration of mediator 
TMPD present in the WE paste. On the contrary, the diffusion coefficient increased 
by enhancing the concentration of the mediator TMPD. 
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Table 12 Screen printed electrodes – Ball Mill 
 
                                 BALL MILL 
Lot No TMPD Concentration Dif. Coefficient RESA CV % 
50 4.595 1.06E-07 0.585 5.84 
51 4.515 7.89E-08 0.649 4.67 
54 3.027 5.98E-08 0.804 4.25 
57 2.846 5.96E-08 0.848 9.55 
41 1.925 3.28E-08 1.219 18.79 
28 2.120 5.22E-08 1.285 14.30 
 
The real electrochemical surface area, the TMPD concentration and the diffusion 
coefficient of the mediator of the other nine lots of electrodes are presented in Table 
13. The working electrode paste of these sensors was prepared using a three roll 
mill. The real electrochemical surface area of these sensors was calculated using 
Chronocoulometry, after determing initially the unknown concentration of the 
mediator incorporated in the working electrode paste and the diffusion coefficient. 
The concentration of the mediator incorporated in the working electrode paste 
ranges from 2.67mM to 4.17mM, while the diffusion coefficient ranges from 5.43e-08 
cm2/sec to 1.06e-07 cm2/sec. By using the Anson equation the real electrochemical 
surface area of each sensor was calculated. 
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Table 13 Screen printed electrodes – Three Roll Mill 
 
                           3 ROLL MILL 
Lot No TMPD Concentration Dif. Coefficient RESA CV % 
114 4.170 7.38E-08 0.550 4.72 
119 3.427 6.87E-08 0.590 14.83 
109 3.860 6.75E-08 0.629 10.08 
72 3.033 5.43E-08 0.637 10.45 
71 3.455 7.29E-08 0.727 8.99 
112 3.139 7.80E-08 0.735 7.071 
118 3.419 6.24E-08 0.807 10.44 
115 3.250 6.78E-08 0.835 9.88 
91 2.671 6.17E-08 0.853 8.01 
 
 
3.3.2 HAEMATOCRIT EFFECT-ADSORPTION OF THE BLOOD SAMPLE INTO 
THE WORKING ELECTRODE PASTE ACCORDING TO THE HAEMATOCRIT 
LEVELS 
 
The hydrophobicity of a surface can be quantified by depositing a small droplet on 
the surface and then measuring the angle between the advancing liquid and the 
surface. This angle is referred as the contact angle. (78). In Figure 23 the contact 
angles obtained between the WE paste and blood samples with different haematocrit 
levels are shown. According to the contact angles the surface of the WE paste is 
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converted to more hydrophilic or hydrophobic in accordance with different 
haematocrit levels of each blood sample. More specifically the blood samples with 
haematocrit lower than 27% and consequently contact angle lower than 90o, convert 
the surface of the WE paste to being more hydrophilic. The blood samples with 
heamatocrit greater than 27% and consequently contact angle greater than 90o, 
create a hydrophobic surface.  
This hydrophobicity or hydrophilicity may interfere with the adsorption of the blood on 
the WE paste. According to the results obtained there is a significant difference of 
adsorption between the blood samples with different haematocrit level, but the 
overall adsorption in accordance with time is not very significant. More precisely, 
blood samples with low haematocrit can be adsorbed easier, since the contact angle 
is lower and consequently the hydrophobicity of the surface of the WE paste, than 
blood samples with high haematocrit level. 
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Figure 23 Contact angle measurements on blood samples (haematocrit level 25%-
40%) (each measurement is the average value of 5 replicates) 
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3.2 AN AMPEROMETRIC GLUCOSE OXIDASE BIOSENSOR USING AN 
ELECTROCHEMICALLY GENERATED CONDUCTING POLYMER 
 
The aim of this study was the characterisation of this new conducting polymer N-(N, 
N’-diethyldicarbamoyl ethyl amido ethyl) aniline (NDDEAEA), which can potentially 
be used in the construction of novel Pelikan electrodes with enhanced integration 
functionalities, e.g. grafting non-adhesive polymer coatings and the development of 
an amperometric glucose biosensor. 
 
3.2.1 ELECTROCHEMICAL POLYMERISATION OF NDDEAEA 
 
Figure 24 shows the electrochemical polymerisation of NDDEAEA by cyclic 
voltammetry. The cyclic voltammograms were obtained during deposition of 0.1M 
NDDEAEA (in 0.75 M HCl  and 25% Acetonitrile, 3:1 solution) within the potential 
range of -0.2 to + 0.9 V at a scan rate of 100 mV s-1 for 20 potential scans, on gold 
screen printed electrode. 
The cyclic voltammograms show an anodic peak at +0.65V and a cathodic peak at 
+0.52V. The large currents observed at the positive end of the cyclic voltammograms 
are due to the electron transfer from the poly (NDDEAEA) film corresponding to the 
oxidation of the PANI film and due to the electron transfer from the NDDEAEA 
monomer to the electrode corresponding to the oxidation of the NDDEAEA monomer 
to produce a precursor for the PANI film. 
 
  
CHAPTER 3 – Results 
 
90 
 
 
 
 
Figure 24 Cyclic voltammetric responses obtained during deposition of NDDEAEA 
on gold screen-printed electrode 
 
The stability of the of poly(NDDEAEA) was investigated by dipping the 
electropolymerised electrodes in 0.75M HCl solution, while running cyclic 
voltammetry, under the same conditions of depositing 0.1M NDDEAEA on the gold  
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screen printed electrodes. The peaks current obtained prove the stability of the 
electropolymerised electrode. (Figure 25) 
 
 
 
Figure 25 Stability of poly (NDDEAEA) 
 
3.2.2 INIFETRER ACTIVATION AND PHOTOCROSSLINKING OF 
ELECTROPOLYMERISED FILMS OF NDDEAEA 
 
When the Poly(NDDEAEA)-modified electrode introduced in 0.75M HCl and 
irradiated with UV light, a photochemical cleavage of the C-S bond occurred, and a 
pair of free radicals was formed. The free radicals present very different reactivities, 
including a reactive carbon-centered radical and a low reactivity (sometimes known 
as dormant) dithiocarbamate radical. This process is reversible. Upon UV irradiation, 
electropolymerised poly(NDDEAEA) generated dormant DTC radicals and active 
carbon centered radicals, thereby acting as an iniferter. 
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Figure 26 shows the cyclic voltammetric response of poly (NDDEAEA) before and 
after irradiation. The first voltammogram (A) observed is due to the cyclic 
voltammetric response of the electropolymerised poly (NDDEAEA). The second CV 
(B) is the cyclic voltammetric response of poly (NDDEAEA) after the first irradiation 
and the third one (C) is after the second irradiation. The oxidation peak currents 
obtained confirmed the formation of radicals due to UV light irradiation. 
 
 
 
 
Figure 26 Cyclic voltammetric responses of poly (NDDEAEA) before and after UV 
irradiation 
 
3.2.3 PHOTOGRAFTING OF VARIOUS MONOMERS ONTO 
ELECTROPOLYMERISED FILMS NDDEAEA 
 
Surface macromolecular architectural designs using photografting experiments 
based on the photochemistry of DTC moieties of NDDEAEA were successfully 
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methacrylic acid, styrene or AMPSA in acetonitrile was UV irradiated under a 
nitrogen atmosphere for 20 minutes Photolysis of the iniferter component of 
poly(NDDEAEA) modified electrode surfaces by UV irradiation yields a pair of 
radicals, an active carbon centered radical which can react with another monomer 
such as MAA or styrene to yield a radical polymer end and a dormant DTC species 
which reacts weakly or not at all with these monomers but can undergo to 
termination reactions through recombination with a growing polymeric chain.(Figures 
27 & 28)  
 
 
 
Figure 27 Electrochemical polymerisation of NDDEAEA giving rise to PANI (PANI) 
chains with pendant dithiocarbamate moieties. 
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Figure 28 Scheme representative of photografting of various monomers onto 
electropolymerised film of NDDEAEA 
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Grafted polymeric surfaces were characterized by Contact Angle (CA) 
measurements. In Table 14, are presented the static contact angle measurements of 
various grafted polymeric surfaces.  
 
Table 14 contact-angle measurements of various grafted polymeric surfaces 
 
Nature of the surface Water contact angle (º) 
Pretreated Screen-printed gold Electrode 
(SPE) 
66.06 
Electropolymerised poly(NDDEAEA) 29.46 
Electropolymerised poly(NDDEAEA after 
UV irradiation 
23.75 
Poly(MAA) surface-grafted to 
electropolymerised poly(NDDEAEA) film 
45.12 
Poly(AMPSA) surface-grafted to 
electropolymerised poly(NDDEAEA) film 
33.07 
Poly(Styrene) surface-grafted to 
electropolymerised Poly(NDDEAEA) film 
64.4 
Poly(Styrene) over poly(MAA) surface-
grafted to electropolymerised 
poly(NDDEAEA) film (layer-by–layer 
grafting) 
64.39 
 
As expected, the contact angle measurements demonstrate that the 
electropolymerised poly (NDDEAEA) was quite hydrophilic with CA of 29.4º and 
became more hydrophilic after UV-irradiation (23.7º), this might be due to generation 
of free-radicals. Poly (MAA) grafted layer was moderately hydrophobic with a contact 
angle of 45.1º, while poly (AMPSA) was more hydrophilic (CA of 33.0 º) this might be 
due to its high acidic sulfonic acid moiety present in AMPSA. On the other hand, 
polystyrene layer was hydrophobic with contact angle of 64.4º. Thus, the contact 
angle measurements can be used to follow the growth of polymeric bilayer upon 
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reinitiation of the polymerization of a second monomer (Styrene) over the first one 
(MAA). The contact angle measurements (before and after the attachment of 
styrene) show quantitative changes in hydrophobicity as expected (CA of 64.5º). 
 
The grafting of the monomers was also observed by SEM and AFM measurements. 
SEM (Figures 29-33) reveals a globular structure of the pre-treated SPE surface 
which displays an obvious change (some holes appear) associated with the 
electropolymerisation of NDDEAEA. After grafting of hydrophilic monomers, MAA 
and AMPSA over electropolymerised poly(NDDEAEA), the films show rather smooth 
surfaces and compact film structures compared to the surface with grafted styrene 
which displayed some uneven hollow structures. These results directly imply that the 
presence of acetonitrile enhances the phase separation and structure heterogeneity 
during the pore generation stage since styrene is a hydrophobic monomer. 
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Figure 29 SEM image of surface morphology of pre-treated gold screen-printed 
electrode 
 
 
Figure 30 SEM image of surface morphology of electropolymerized NDDEAEA 
electrode 
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Figure 31. SEM image of surface morfology of electropolymerised NDDEAEA 
grafted with MAA 
 
 
Figure 32 SEM image of surface morfology of electropolymerised NDDEAEA grafted 
with AMPSA 
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Figure 332 SEM image of surface morfology of electropolymerised NDDEAEA 
grafted with stryrene 
 
AFM measurements are also made on various modified surfaces prepared by 
electropolymerisation of NDDEAEA and grafting of poly(MAA), poly(AMPSA) and 
polystyrene over an electropolymerised NDDEAEA layer (Figures 34-39). As can be 
seen, the bare gold electrode displays a typical grainy morphology over some hollow 
structure. Electropolymerisation of the NDDEAEA leads to deposition of polymer on 
the surface, smoothing out many of these features with some spikes on it which 
increases by UV irradiation. Following grafting with poly(methacrylic acid) and 
poly(AMPSA) by activating the dithiocarbamate part of the NDDEAEA, the surface 
became smoother. Meanwhile grafting of polystyrene over the electropolymerised 
NDDEAEA shows some holes and bumps in the polymer layer which might be due to 
phase separation in acetonitrile. Layer by layer grafting of polystyrene over 
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poly(methacrylic acid) also displayed this type of behavior which proves that the 
dithiocarbamate radical can be activated again due to UV irradiation. 
 
 
 
Figure 34 AFM of bare pre-treated gold SPE 
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Figure 35 AFM of electropolymerised NDDEAEA film on pre-treated gold SPE after 
15 min irradiation 
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Figure 36 Poly (methacrylic acid) film grafted over electropolymerised NDDEAEA by 
iniferter activation using UV irradiation 
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Figure 373 Poly (AMPSA) film grafted over electropolymerised NDDEAEA by 
iniferter activation using UV irradiation 
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Figure 38 Poly (styrene) film grafted over electropolymerised NDDEAEA by iniferter 
activation using UV irradiation 
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Figure 39 Layer by layer grafting of Poly (styrene) film over poly (methacrylic acid) 
over electropolymerised NDDEAEA by iniferter activation using UV irradiation 
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3.2.4 IMMOBILISATION OF GLUCOSE OXIDASE OVER 
ELECTROPOLYMERISED NDDEAEA BY INIFERTER ACTIVATION USING UV 
IRRADIATION  
 
i) GOx loading 
In order to immobilise GOx over electropolymerised NDDEAEA an 
electropolymerised poly (NDDEAEA)-modified SPE was placed horizontally in a 
glass vial and UV irradiated after applying 150 µL of different concentrations of GOx 
on the electrode surface, for 15 minutes. A maximum current was obtained when 
30mg/ml GOx was used. The cyclic voltammetric response of immobilised GOx over 
electropolymerised NDDEAEA in the presence of glucose is presented in Figure 40. 
 
 
 
Figure 40 The cyclic voltammetric responses of immobilised GOx over 
electropolymerised NDDEAEA in the presence of glucose 
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The electrochemical response of the biosensor to glucose was examined using 
cyclic voltammetry. It was demonstrated that the current response of the NDDEAEA 
/GOx electrode measured in 0.1 M PBS pH 7.5 (the specific pH reflects the optimum 
conditions for enzymatic mediated electrochemical reactions) after adding different 
concentrations of glucose increases with the increased concentrations of glucose. 
 
ii) Working Potential 
The effect of applied potential on the amperometric response of the biosensor to 
glucose was investigated with the NDDEAEA /GOx electrode to glucose. In Figure 
41 is presented the dependence of the amperometric response current to 0.5mM 
injection of glucose. The applied potential tested varied from 0 to 0.6V. The response 
increased when the applied potential was increased from 0 to 0.4V, while further 
increase of the applied potential, resulted in the decrease of the amperometric 
response. In order to minimize interferences and achieve the lowest detection limit 
the working potential was set at 0.35V, as the optimum applied potential for the 
amperometric measurements. 
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Figure 41 Current response at different applied potentials 
 
iii) Glucose calibration curve 
Figure 42 shows the calibration curve of NDDEAEA /GOx electrode obtained in 0.1M 
PBS pH 7.5 at a potential of 0.35V with the consecutive additions of glucose. The 
specific biosensor presents a linear response to glucose concentration within the 
range from 0.1mM to 5 mM with a correlation coefficient of 0.9775. When glucose 
concentration is higher than 20mM plateau current was observed. The sensitivity of 
the biosensor is 3.293µA mM-1, while the limit of detection is 69.81µM. 
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Figure 42 Calibration curve of NDDEAEA /GOx electrode 
 
iv) Interference study 
Some substances existed in biological samples could interfere with the detection of 
glucose. Ascorbic acid, sucrose and uric acid are the most common reducing agents 
present in biological samples, which may be electrochemically oxidized and interfere 
with the detection of glucose. 
Figure 43 shows the current response of NDDEAEA /GOx electrode for the addition 
of 0.5mM of glucose in 0.1M PBS pH 7.5, followed by consecutive additions of 
ascorbic acid, sucrose and uric acid. (concentration range 0.1mM to 10mM) 
 
  
0.00E+00
5.00E-06
1.00E-05
1.50E-05
2.00E-05
2.50E-05
0 5 10 15 20 25 30
C
u
rr
e
n
t 
A
m
p
s 
[Glucose] mM 
Calibration Curve 
 
CHAPTER 3 – Results 
 
110 
 
 
 
 
Figure 43 Current response of NDDEAEA /GOx electrode for the addition of 0.5mM 
of glucose, followed by consecutive additions of ascorbic acid, sucrose and uric acid. 
(concentration range 0.1mM to 10mM) 
 
Table 15 Interference of uric acid, ascorbic acid and sucrose on response to glucose 
at NDDEAEA /GOx electrode at 0.35V working potential. 
 
Ratio of 
Glucose to 
interferents 
Uric Acid Ascorbic Acid Sucrose 
1:1 8.53% 4.26% 3.21% 
1:2 15.60% 5.40% 22.80% 
1:10 17.65% 6.53% 26.60% 
1:20 14.71% 7.67% 54.81% 
 
It is observed that uric acid, ascorbic acid and sucrose in one to one ratio with 
glucose affected the amperometric response to a small extend, up 8.5% for uric acid, 
4.26% for ascorbic acid and 3.21% for sucrose. It is worthy to note though that the 
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usual concentration of uric acid in the blood sample is 0.116 mM to 0.472mM, while 
for ascorbic acid is 0.022mM to 0.083mM. Consequently the specific interference 
compounds will not affect the sensor response. 
 
3.3 DEVELOPMENT AND OPTIMISATION OF THE REACTION CONDITIONS TO 
GRAFTING HYPERBRANCHED POLYMER ONTO THE SURFACE OF THE 
MULTI-WALLED CARBON NANOTUBES 
 
The purpose of this study was to develop and optimise the reaction conditions to 
grafting a hyperbranched polymer onto the surface of the multi-walled carbon 
nanotubes (MWCNT), using the A3 + B2 approach. By this study we aimed to explore 
a further advanced approach to significantly increase the sensitivity of Pelikan SPEs. 
 
3.3.1 GRAFTING AND CHARACTERISATION OF HYPERBRANCHED POLYMER 
ONTO MWCNTs 
 
Initially the pristine MWCNT were acidic treated in order to produce carboxylic acid 
functionalised MWCNTs. The MWCNT-COOH was suspended in SOCl2 in order to 
generate MWCNT-COCl. And finally the aminated MWCNTs were produced by 
reacting MWCNT-COCl with H2NC2H4NH2. The peaks retrieved in the IR spectra 
shown in Figure 44 are in agreement with the desired results. In more details the 
carbonyl bond (C=O) assigned to oxidised MWCNTs (MWNT-COOHs) occurs at 
1720 cm-1, while the absorption at 3430 cm-1 indicates the presence of hydroxyl 
groups. Moreover the N-H stretching absorption is less sensitive to hydrogen 
bonding than are O-H absorptions. The peaks retrieved at 1000 to 1350 cm-1 are 
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attributed to the C-N stretching absorptions. The results of FTIR spectra confirm the 
desired functionalisation/modification of the raw MWNT after treatment. 
 
 
Figure 44 FT-IR spectra of MWCNTs 
 
The SEM images of pristine (A), oxidised (B) and aminated (C) MWCNTs are shown 
in Figure 45. As can been seen the pristine MWCNTs present smooth surfaces in 
comparison with the treated MWCNTs. 
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Figure 45 SEM images of pristine (A), oxidised (B) and aminated (C) MWCNTs. 
(magnification: 100kx and scale bar:200nm) 
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The molecular architecture of three dimensional macromolecules such as the 
hyperbranched polymers present a globular format. (79) Hyperbranched polymer 
attached to the MWCNTs can be observed in the SEM images that follow.  
 
i) First approach of grafting a hyperbranched polymer onto MWCNTs using the 
A3+B2 approach 
On the first approach the aminated MWCNTs (10wt%) were introduced in the 
ultrasonic bath for 15 minutes in the presence of 100 mL of dried ethanol. The A3 
(1,1′-Ferrocenedicarboxaldehyde) and B2 (Tris(2-aminoethyl)amine) monomers 
(molar ratio 1:1) were added and stirred at room temperature for 30 minutes. After 
they were refluxed for 8 or 24 hours at 80 oC, they were let to cool down at room 
temperature. The reduction step was then followed by adding a 2.5eq. of sodium 
borohydride. Finally the mixture was submitted to vigorous stirring for 24 hours. The 
product was collected by suction filtration, using a 0.22µm polycarbonate membrane 
and further Soxhlet extracted in tetrahydrofuran for 24 hours at 66 oC. The final 
product was dried in the vacuum oven at 40oC for 24 hours. 
 
Figure 46 shows that the hyperbranched polymer grafted onto MWCNTs using the 
A3+B2 approach by setting the reflux time at 8 hours, while Figure 47 shows the 
hyperbranched polymer grafted onto MWCNTs using the A3+B2 approach by setting 
the reflux time at 24 hours. It was observed that many carbon tubes were 
aggregated to form bundles. Due to the polar surfaces of the MWCNTs, attributed to 
the amino groups present, there is an assembling tendency to form tetragonal or 
hexagonal packing. The average diameter of the modified MWCNTs is 
approximately 100nm, which is approximately three times thicker than the 
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unmodified MWCNTs.Thus it is suggested that by modifying the reflux time of the 
reaction, an overall increased degree of aggregation has been noticed. 
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Figure 46 Hyperbranched polymer grafted onto MWCNTs using the A3+B2 approach 
(1st method-reflux time for 8 hours) 
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Figure 47 Hyperbranched polymer grafted onto MWCNTs using the A3+B2 approach 
(2nd method-reflux time for 24 hours) 
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ii) Second approach of grafting a hyperbranched polymer onto MWCNTs from 
A3+B2 approach 
The aminated MWCNTs (10wt%) were introduced in the ultrasonic bath for 15 
minutes in the presence of 100mL of N-Methyl-2-pyrrolidon. 30mM of B2 (Tris(2-
aminoethyl)amine) monomer was mixed with two catalysts:  the triphenylphosphit 
and the pyridine in a concentration 10 times higher than the concentration of the 
monomer and refluxed at 90 oC for 1 hour. After the addition of 30mM of A3 (1,1′-
Ferrocenedicarboxaldehyde) monomer and calcium chloride, in a 3 times higher 
concentration of the starting material, the mixture was allowed to reflux at 90 oC for 8 
or 24 hours. The product was collected by suction filtration, using a 0.22µm 
polycarbonate membrane and further Soxhlet extracted in tetrahydrofuran for 24 
hours at 66 oC. The final product was dried in the vacuum oven at 40oC for 24 hours 
 
Figure 48 shows the hyperbranched polymer grafted onto MWCNTs using the A3+B2 
approach by setting the reflux time at 8 hours, while Figure 49 shows the 
hyperbranched polymer grafted onto MWCNTs using the A3+B2 approach by setting 
the reflux time at 24 hours. It was observed that many tubes were aggregated to 
form bundles, but no formations of polymers are visible on the surfaces of the 
MWCNTs. 
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Figure 48 Hyperbranched polymer grafted onto MWCNTs from A3+B2 approach (2
nd 
method-reflux time at 8 hours) 
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Figure 49 Hyperbranched polymer grafted onto MWCNTs from A3+B2 approach 
(second method-reflux time at 24 hours) 
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4.1 PELIKAN SUN: A COMMERCIAL AMPEROMETRIC GLUCOSE OXIDASE 
BIOSENSOR 
 
4.1.1 DETERMINATION OF THE REAL ELECTROCHEMICAL SURFACE AREA 
OF THE PELIKAN WORKING ELECTRODE. 
 
Several studies (80) have shown the close relation between the active 
electrochemical surface area of the working electrode and the concentration range of 
the detected analyte (glucose). In general, high surface area electrodes are desired 
as the high surface area provides more active sites for electrochemical reactions, 
and hence higher kinetic rate capability (US patent 5728181). Therefore, the 
determination of the active electrochemical surface area of the electrode is very 
important. There are several methods, in order to calculate the real electrochemical 
surface area of the electrode. The principal method applied in this study was 
chronocoulometry, since it is a simple electroanalytical technique with many 
applications. (81) 
In detail, the preliminary studies on the determination of the real electrochemical 
surface area of a glassy carbon electrode was carried out, followed by the real 
electrochemical surface studies of  Acheson and Dupont screen printed electrodes, 
which are physically and structurally identical to the Pelikan screen printed 
electrodes. However, their working electrode paste was made of plain carbon paste 
only without enzyme (glucose oxidase), mediator (TMPD) and several buffers. The 
results obtained using the glassy carbon electrode were consistent, resulting in really 
low percentage of coefficient of variation. It was further found that there is a close 
relation among the concentration of the mediator, the diffusion coefficient and the 
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real electrochemical surface area of the electrode. By increasing the concentration of 
the mediator in the solution, the diffusion coefficient increased whilst the real 
electrochemical surface area of the electrode decreased. 
The experimental performance on the actual Pelikan screen printed electrodes was 
investigated. After managing successfully to solve several contretemps related to the 
standard addition method used for calculating the unknown concentration of the 
mediator incorporated in the working electrode paste, we managed to optimise the 
method and successfully use it to determine the real electrochemical surface area of 
the Pelikan electrodes. 
The final optimisation of the method to determine the real electrochemical surface 
area of screen printed electrodes was adopted by Pelikan as a potential evaluation 
method of their screen printed electrodes.  
 
4.1.2 HAEMATOCRIT EFFECT-ADSORPTION OF THE BLOOD SAMPLE INTO 
THE WORKING ELECTRODE PASTE ACCORDING TO THE HAEMATOCRIT 
LEVELS 
 
The haemetocrit differences observed in the blood samples can significantly affect 
glucose measurements. The most pronounced haematocrit effects occur at low and 
at high haematocrit levels, which generally increase and decrease glucose 
measurements, respectively (82). High heamatocrit levels up to 62.9% are presented 
to newborns with polycythemia and low heamatocrit levels are observed commonly 
to people with renal failure, hemodialysis and cardiopulmonary bypass (83). Several 
CHAPTER 4 – Discussion 
 
124 
 
studies have shown the possible mechanisms of the heamatocrit effects on glucose 
meter measurements. These mechanisms include the mechanically impede diffusion 
of plasma into the reagent layer, because of the increased number of erythrocytes in 
the whole blood sample or because of the decreased volume of plasma available to 
diffuse (84). The blood consists of plasma and particles such as the red blood cells. 
The viscosity of blood depends on the viscosity of plasma in combination with the 
heamatocrit. High heamatocrit level implies higher viscosity and consequently 
decrease of the fluid permeability into the reagent layer (85). 
The reagent layer in the Pelikan Electrodes is the working electrode, consisting of 
the WE paste. By using a contact angle goniometer the interaction of blood samples 
with different haematocrit levels was observed with the WE paste. Whole blood 
samples with heamatocrit levels between 25 to 40 percent were tested. The results 
obtained showed that there is a significant difference of adsorption between the 
blood samples with different heamatocrit level, but the overall adsorption in 
accordance with time was not very significant. This adsorption can be also attributed 
to the hydrophobicity of the WE paste. In general, factors which influence the 
hydrophobicity of the surface are the nature of the material itself and the microscopic 
morphology of the surface (86). Blood samples with heamatocrit lower than 27% and 
consequently contact angle lower than 90o, convert the surface of the WE paste to 
more hydrophilic, while blood samples with heamatocrit greater than 27% and 
consequently contact angle greater than 90o, convert the surface of the WE paste to 
more hydrophobic. Finally blood samples with low heamatocrit can be absorbed 
easier, since the contact angle is lower and consequently the hydrophobicity of the 
surface of the WE paste, than blood samples with high heamatocrit level. 
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4.2 AN AMPEROMETRIC GLUCOSE OXIDASE BIOSENSOR USING AN 
ELECTROCHEMICALLY GENERATED CONDUCTING POLYMER 
 
Conducting polymers (CPs) especially Polyanilines (PANIs) are receiving great 
attention as a result of their promising properties for optoelectronic applications such 
as sensors, solar cells, and light-emitting diodes (87), (88), (89). One of the major 
drawbacks of these polymers is their insoluble nature. Many studies have been 
performed (90), (91), (92) for modifying the polymer’s surface, by mainly introducing 
functional groups onto the polymer surface in order to improve the surface 
hydrophilicity. Molecular design is the best mean at the moment for introducing 
functional groups onto polymer substrates and this can be achieved by 
functionalizing conjugated polymers.  
 
The new conducting polymer N-(N, N’-diethyldicarbamoyl ethyl amido ethyl) aniline 
(NDDEAEA), which is characterized and acts as a matrix for the biosensor 
fabrication in this study, can act as a macroiniferter and is capable of electrochemical 
polymerisation to form PANI-based materials in various formats capable of utilization 
in other reactions, such as participation in free radical-initiated addition 
polymerisation after formation of the PANI material while preserving or even 
enhancing some of the PANI’s properties (such as electrical conductivity) (93). 
The basic research in this study rely on the characterisation of the NDDEAEA, the 
optimization of the conditions for the electrochemical polymerization, their application 
in grafting and finally the development of a glucose biosensor.  
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4.2.1 Electrochemical polymerisation of NDDEAEA 
More precisely electrochemical polymerisation was used for polymerising NDDEAEA 
through its aniline functionality to generate conducting PANI chains. The 
electrochemical characterisation was carried out using cyclic voltammetry and the 
results obtained are quite similar to that obtained during the polymerisation of aniline 
and ring substituted anilines dissolved in acidic solutions. (94), (95), (96), (97), (98), 
(99) The large currents observed at the positive end of the CV are due to the 
superposition of two distinct processes: one is the electron transfer from the poly 
(NDDEAEA) film corresponding to the oxidation of the PANI film and the other is the 
electron transfer from the NDDEAEA monomer to the electrode corresponding to the 
oxidation of the NDDEAEA monomer to produce a precursor for the PANI film.  
 
Iniferter-activation and photocrosslinking of electropolymerised films of NDDEAEA 
When the poly(NDDEAEA)-modified electrode was irradiated with UV light in 0.75M 
HCl, a photochemical cleavage of the C-S bond occurred, as well as the formation of 
a pair of free radicals which have very different reactivities, such that a reactive 
carbon-centered radical and a low reactivity  dithiocarbamate radical (sometimes 
known as dormant). This process is reversible. The end groups of the polymers can 
be cross-linked by only photoirradiation without the use of any chemical crosslinker 
such as di-isocyanates which can be harmful to the environment. Upon UV 
irradiation, the electropolymerized poly(NDDEAEA) generated dormant DTC radicals 
and active carbon centered radicals, thereby acted as an iniferter. 
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4.2.2 Photografting of various monomers onto electropolymerised film of 
NDDEAEA 
In the presence of various monomers such as methacrylic acid (MAA) or styrene this 
allowed precise grafting with control of the macromolecular architectures of the 
grafted surfaces. Water contact angle measurements before and after UV irradiation 
in monomer solution provided evidence that the graft polymerisation proceeded only 
during photoirradiation. 
 
In more details, electropolymerised films of poly(NDDEAEA) were UV irradiated in a 
monomer solution (MAA, styrene or AMPSA) under a nitrogen atmosphere for 20 
minutes Photolysis of the iniferter component of poly(NDDEAEA)-modified electrode 
surfaces by UV irradiation yielded in a pair of radicals, an active carbon centered 
radical which can react with another monomer such as MAA or styrene to yield a 
radical polymer end and a dormant DTC species which reacts weakly or not at all 
with these monomers but can undergo to termination reactions through 
recombination with a growing polymeric chain. The grafted polymeric surfaces were 
characterized by Contact Angle (CA) measurements. Controlling the surface contact 
–angle through changes in the surface functionality, while retaining the bulk material 
properties, is useful for many applications, including sensors, flow control and cell 
Patterning. 
 
By using the electropolymerised NDDEAEA with DCT groups as substrates for the 
surface-initiated photopolymerisation of MAA, AMPSA and styrene into 
homopolymers and layer by layer grafted polymer, the “living” nature of the iniferter 
was proven. The ‘living’ nature of the photopolymerisation has been also proved with 
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the formation of copolymer layers with consecutive use of two different monomers. 
According to several studies this type of polymeristaion can undergo difficulties 
regarding the photolysis of DTC end groups on poly (MAA) growing end, resulting in 
a less efficient grafting of second layer  (100), (101), however, in this study has been 
confined a two dimensional photopolymerisation processes, due to the presence of 
high density of DTC groups; therefore the surface-growing polymer end explores 
only a two-dimensional space and grows in a uniform way for the first and second 
polymeric layer. 
 
4.2.3 Immobilisation of glucose oxidase over electropolymerised NDDEAEA by 
iniferter activation using UV irradiation  
There are several methods in order to immobilise the enzymes, such as adsorption, 
physical entrapment, crosslinking and covalent bonding. (102) and evethough PANI 
has been used not only for physical entrapment but also as a matrix for covalent 
enzyme immobilization, in this study has been successfully demonstrated the 
immobilisation of glucose oxidase onto a polyaniline derivative polymer matrix by 
iniferter activation using UV irradiation. The NDDEAEA/GOx electrode presented a 
linear response to glucose concentration within the range from 0.1mM to 5 mM with 
a correlation coefficient of 0.9775. A plateau current was observed when the glucose 
concentration was higher than 20mM. The sensitivity of the biosensor was 3.293µA 
mM-1, while the limit of detection was 69.81µM. Regarding the interference 
substances it was observed that uric acid, ascorbic acid and sucrose in one to one 
ration with glucose affected the amperometric response to a small extend, up 8.5% 
for uric acid, 4.26% for ascorbic acid and 3.21% for sucrose. It is worthy to note 
though that the usual concentration of uric acid in the blood sample is 0.116 mM to 
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0.472mM, while for ascorbic acid is 0.022mM to 0.083mM. Consequently the specific 
interference compounds will not affect the sensor response. 
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4.3 DEVELOPMENT AND OPTIMISATION OF THE REACTION CONDITIONS TO 
GRAFTING HYPERBRANCHED POLYMER ONTO THE SURFACE OF THE 
MULTI-WALLED CARBON NANOTUBES 
 
Multi-walled carbon nanotubes have attracted much attention due to their 
mechanical, electrical and thermal properties and their wide range of applications, 
including sensors, electronics, and energy storage devices. (79), (103), (104) 
 
The major drawback though of the MWCNTs is their luck of solubility in organic and 
aqueous solutions and consequently their significant luck of exploitation in many 
commercial applications. By attaching small molecules or macromolecules, such as 
polymers, on the surface of nanotubes and by altering their functionality, scientists 
have overcome this problem and a significant progress in their study and application 
has been succeeded. (105) 
 
The functionalisation of carbon nanotubes with polymers can be achieved by several 
techniques, such as living radical polymerisation, living anionic polymerisation and 
ring opening polymerisation. The living radical polymerisation is based on the 
covalent functionalisation of the nanotube sidewalls by two different methods, the 
“grafting to” and the “grafting from” methods. The “grafting to” method is achieved by 
attaching a preformed polymer chain onto the surface of pristine or prefunctionalised 
nanotubes, while the “grafting from” method, the method used in our study, is 
achieved by polymerising monomers from surface derived initiators on MWCNTs. 
(103) 
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More precisely 1,1′-Ferrocenedicarboxaldehyde and Tris(2-aminoethyl)amine were 
polymerised as A2 and B3 monomers respectively, using two different methodologies 
and they were then grafted onto MWCNTs following the “grafting from” approach. 
 
A successful grafting was achieved by using the first method. As can be observed 
from the SEM images many tubes were aggregated to form bundles and the average 
diameter of the modified MWCNTs was approximately 100nm, which is 
approximately three times thicker than the unmodified MWCNTs. In comparison by 
using the second method, the SEM images obtained do not show any specific 
formation of polymer on the MWCNT surfaces. This is probably due to the effects of 
co-factors such as the monomer reactivity, the monomer concentration, or the 
solvent used. Several studies (106) have demonstrated that the reactivity of the 
monomer is a very important factor in grafting, since it is closely related to several 
factors such as the polar and steric nature, swellability of backbone in the presence 
of the monomers and concentration of monomers. Regarding the solvent used it is 
worthy to note that in general in grafting mechanisms, the solvent is the carrier by 
which monomers are transported to the vicinity of the backbone, so it plays a very 
important factor for a successful polymerisation. 
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This project aimed at better understanding and improvements in performance of 
glucose biosensors, in particular these produced by Pelikan – sponsor of this work. 
 
The first part of the study included the study of different aspects of the Pelikan 
screen printed electrodes. More precisely the determination of their real surface area 
and an investigation regarding the major haematocrit effect which most of the 
present commercial electrochemical glucose biosensors seem to present was 
carried out.  
 
The determination of the active electrochemical surface area of the electrode is very 
important since high surface area electrodes are desired as the high surface area 
provides more active sites for electrochemical reactions, and hence higher kinetic 
rate capability (US patent 5728181) The principal method applied in this study was 
chronocoulometry, since it is a simple electroanalytical technique with many 
applications. (Bott et al., 2005) In detail, the preliminary studies on the determination 
of the real electrochemical surface area of a glassy carbon electrode was carried 
out, followed by the real electrochemical surface studies of  Acheson and Dupont 
screen printed electrodes, which are physically and structurally identical to the 
Pelikan screen printed electrodes. However, their working electrode paste was made 
of plain carbon paste only without enzyme (glucose oxidase), mediator (TMPD) and 
several buffers. The results obtained, using the glassy carbon electrode were 
consistent, resulting in really low percentage of coefficient of variation. It was further 
found that there is a close relation among the concentration of the mediator, the 
diffusion coefficient and the real electrochemical surface area of the electrode. By 
increasing the concentration of the mediator in the solution, the diffusion coefficient 
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increased whilst the real electrochemical surface area of the electrode decreased. 
The experimental performance on the actual Pelikan screen printed electrodes was 
investigated and the method determing the real electrochemical surface area of 
screen printed electrodes was adopted by Pelikan as a potential evaluation method 
of their screen printed electrodes.  
 
It is worthy to note that the close relation among the concentration of the mediator, 
the diffusion coefficient and the real electrochemical surface area of the electrode 
necessitates a further testing of the glucosensors with the actual blood sample, since 
all the measurements carried out in this research involved the use of buffers.  
 
Another very important factor that can influence significantly the glucose 
measurements is the haemetocrit differences observed in the blood samples. The 
most pronounced haematocrit effects occur at low and at high haematocrit levels, 
which generally increase and decrease glucose measurements, respectively (82). 
The results obtained, retrieved from our study showed that there is a significant 
difference of absorption between the blood samples with different heamatocrit level, 
but the overall absorption in accordance with time was not very significant. This 
absorption can be also attributed to the hydrophobicity of the WE paste. In general, 
factors which influence the hydrophobicity of the surface are the nature of the 
material itself and the microscopic morphology of the surface (86). Blood samples 
with heamatocrit lower than 27% and consequently contact angle lower than 90o, 
convert the surface of the WE paste to more hydrophilic, while blood samples with 
heamatocrit greater than 27% and consequently contact angle greater than 90o, 
convert the surface of the WE paste to more hydrophobic. Finally blood samples with 
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low heamatocrit can be absorbed easier, since the contact angle is lower and 
consequently the hydrophobicity of the surface of the WE paste, than blood samples 
with high heamatocrit level. 
 
The second part of the study included the characterisation of the NDDEAEA, the 
optimization of the conditions for the electrochemical polymerization, its application 
in grafting and finally the development of a glucose biosensor. 
 
The new conducting polymer N-(N, N’-diethyldicarbamoyl ethyl amido ethyl) aniline 
(NDDEAEA), which was characterized and acted as a matrix for the biosensor 
fabrication in this study, can act as a macroiniferter and is capable of electrochemical 
polymerisation to form PANI-based materials in various formats capable of utilization 
in other reactions, such as participation in free radical-initiated addition 
polymerisation after formation of the PANI material while preserving or even 
enhancing some of the PANI’s properties. More precisely electrochemical 
polymerisation was used for polymerising NDDEAEA through its aniline functionality 
to generate conducting PANI chains. The electrochemical characterisation was 
carried out using cyclic voltammetry and the results obtained were quite similar to 
that obtained during the polymerisation of aniline and ring substituted anilines 
dissolved in acidic solutions. (94), (95), (96), (97), (98), (99) When the was irradiated 
with UV light in 0.75M HCl, a photochemical cleavage of the C-S bond occurred, as 
well as the formation of a pair of free radicals which have very different reactivities, 
such that a reactive carbon-centered radical and a low reactivity  dithiocarbamate 
radical (sometimes known as dormant). This process was reversible. Upon UV 
irradiation of the poly(NDDEAEA)-modified electrode, the electropolymerized 
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poly(NDDEAEA) generated dormant DTC radicals and active carbon centered 
radicals, thereby acted as an iniferter. Moving forward to photografting various 
monomers onto the electropolymerised poly(NDDEAEA, the “living” nature of the 
iniferter was successfully proven. The ‘living’ nature of the photopolymerisation has 
been also proved with the formation of copolymer layers with consecutive use of two 
different monomers. 
 
The development of the glucose biosensor was achieved by successfully 
immobilising the glucose oxidase onto a polyaniline derivative polymer matrix by 
iniferter activation using UV irradiation. The NDDEAEA/GOx electrode presented a 
linear response to glucose concentration within the range from 0.1mM to 5 mM with 
a correlation coefficient of 0.9775. A plateau current was observed when the glucose 
concentration was higher than 20mM. The sensitivity of the biosensor was 3.293µA 
mM-1, while the limit of detection was 69.81µM. Regarding the interference 
substances it was observed that uric acid, ascorbic acid and sucrose in one to one 
ration with glucose affected the amperometric response to a small extend, up 8.5% 
for uric acid, 4.26% for ascorbic acid and 3.21% for sucrose. It is worthy to note 
though that the usual concentration of uric acid in the blood sample is 0.116 mM to 
0.472mM, while for ascorbic acid is 0.022mM to 0.083mM. Consequently the specific 
interference compounds will not affect the sensor response. 
 
As has already been mentioned the specific compound can potentially be used in the 
construction of novel Pelikan electrodes with enhanced integration functionalities, 
e.g. grafting non-adhesive polymer coatings. In order to achieve this some further 
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studying need to be performed, in order to improve the sensitivity of the sensor and 
the effect of interferences.  
 
The final study included the development and optimisation of the reaction conditions 
to grafting a hyperbranched polymer onto the surface of the multi-walled carbon 
nanotubes (MWCNT), using the A3 and B2 approach.  
 
More precisely 1,1′-Ferrocenedicarboxaldehyde and Tris(2-aminoethyl)amine were 
polymerised as A2 and B3 monomers respectively, using two different methodologies 
following the “grafting from” approach. A successful grafting was achieved by using 
the first method, since on SEM images it was observed that many tubes were 
aggregated to form bundles and the average diameter of the modified MWCNTs was 
approximately 100nm, which is approximately three times thicker than the 
unmodified MWCNTs. By using the second method, the SEM images obtained did 
not show any specific formation of polymer on the MWCNT surfaces. This is 
probably due to the effect of co-factors such as the monomer reactivity, the 
monomer concentration, or due to the solvent used.  
 
Since all the above factors as well as the time and temperatures of the reactions can 
affect the formation and grafting of the polymers onto the MWCNTs a further study is 
needed to be performed. 
 
In conclusion, diabetes is one of the leading causes of death and disability in the 
world. As this field enters the fifth decade of intense research, the market size and 
the huge demand are creating the need for the development of new approaches, 
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allowing the development of a cheap, robust and more importantly reliable 
biosensor. Nowadays commercial blood glucose meters are produced by many 
companies worldwide, but mostly employ mediated amperometric biosensor 
technology. Some other alternative strategies include minimally invasive testing 
meters and continuous glucose monitoring. The incorporation of polymers can 
improve the selectivity and biocompatibility of the biosensors, while the use of 
hyperbranched polymers offer the chance for the development of new products, such 
as a variety of new nanomaterials, when grafted to multiwall carbon nanotubes. 
These and similar developments are expected to greatly improve the control and 
management of diabetes to the overall benefit of the World’s population. 
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Commercial Biosensors for Diabetes 
 
 
Vasiliki Fragkou and Anthony P.F Turner 
Cranfield Health, Cranfield University, Silsoe, MK45 4D, UK 
 
 
 
 
Abstract: Diabetes is a metabolic disorder, which occurs either because of a lack 
of insulin or because of the presence of factors that oppose the action 
of insulin. There is currently no cure for diabetes and the control of 
elevated blood glucose levels, without causing abnormally low levels, is 
the major goal in treating diabetes. Reasonable control is now relatively 
easily achieved with a blood glucose meter / glucose biosensor. 
Currently, there are more than 40 commercialised devices for detecting 
blood glucose levels. As a result of intense competition, companies 
have resorted to a strategy where existing technology has been 
pragmatically optimised to meet commercial objectives, such as small 
size and fast response time.  As a consequence of this continual 
development, commercial practice often differs from the theoretical 
papers appearing in the literature. This chapter will focus on 
commercial biosensors and the underlying science behind their 
functionality. 
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Paper awaiting to be published in Macromolecules Journal 
 
Conjugated Polymers with Pendant Iniferter Units -
Versatile Material for Grafting 
Petya K. Ivanova-Mitseva a, Vasiliki Fragkou a, Dhana Lakshmi a1, Michael J. 
Whitcombe a, Frank Davis a, Antonio Guerreiro a, Joe A. Crayston b, Diana K. 
Ivanovaa , Petar A. Mitsevc , Elena V. Piletska a, and Sergey A. Piletsky a  
a Cranfield Health, Vincent Building, Cranfield University, Cranfield, Bedfordshire, 
MK43 0AL, United Kingdom, b School of Chemistry ,University of St Andrews ,North 
Haugh ,St Andrews , Fife , KY16 9ST , Scotland , United Kingdom , c School of 
Engineering, Cranfield University, Cranfield, Bedfordshire, MK43 0AL, United 
Kingdom. 
ABSTRACT: A novel compound N-(N,N’-diethyldithiocarbamoyl ethyl amido ethyl)-
aniline (NDDEAEA) was synthesized and fully characterized. 
Conjugated poly-NDDEAEA, consisting of N-substituted polyaniline 
(PANI) backbones with dithiocarbamate ester pendant groups (iniferter) 
was synthesized by chemical and electrochemical polymerization. UV-
initiated living polymerization was used to graft styrene, methacrylic 
acid (MAA), lauryl methacrylate (LMAA) and acrylamido-2-
methylpropane sulphonic acid (AMPSA) from the conjugated 
macroiniferter, deposited on various surfaces (glass, polypropylene, 
and polystyrene, gold electrodes). Polymeric surfaces were 
characterized by static contact angle measurements, XPS, SEM and 
AFM. This versatile new material can be used for creating materials 
with integrated functionalities (e.g. conductivity and molecular 
recognition, catalysis, controlled transport properties etc.) for 
application in sensors, microfluidic devices, and surface patterning. 
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Patent: 
 
Title: DETERMINATION OF THE REAL ELECTROCHEMICAL 
SURFACE AREAS OF SCREEN PRINTED ELECTRODES  
Inventors: Norbert Bartetzko , Vasiliki Fragkou, Anthony Turner , and Gregor 
Steiner  
Priority application:  Provisional - US Ser. No. 61/141,159 filed 12/29/2008 
Serial No. 12/640,446 Filed: 12/27/2009  
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SOP-Real electrochemical Surface Area Determination: 
 
Determination of the Real Electrochemical Surface Area of the WE 
PROTOCOL 
 
 
Principle: 
 
Several studies (Chou et al, 2005) have shown the close relation between the active 
electrochemical surface area of the working electrode and the concentration range 
of the detected analyte (glucose). In general, high surface area electrodes are 
desired as the high surface area provides more active sites for electrochemical 
reactions, and hence higher kinetic rate capability (US patent no. 5728181). 
Therefore, the determination of the active electrochemical surface area of the 
electrode is very important. The methods applied include the use of the standard 
addition method for the calculation of the concentration of the mediator in each 
electrode, cyclic voltammetry for the calculation of the diffusion coefficient and 
chronocoulometry for the calculation of the real electrochemical surface area of the 
electrodes. 
 
Abbreviations: 
 
PBS: Phosphate Buffer 
TMPD: N,N,N’,N’-tetramethyl-p-phenylenediamine, CAS:100.22.1 
Diluter - solvent: 2-(1-Methoxy)propyl Acetate 97%, CAS: 108-65-6 
CV: cyclic voltammograms 
Eox: Oxidation peak current 
RESA: real electrochemical surface area 
 
Materials: 
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• Sensors 
• PBS: 10mM PBS,154mM NaCl, pH 7.4 
• Diluter - solvent 
• 50mM TMPD (stock solution) 
• 100µM TMPD (in PBS) 
• 250µM TMPD (in PBS) 
• 500µM TMPD (in PBS) 
• 750µM TMPD (in PBS) 
• 1000µM TMPD (in PBS) 
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